Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3022756	s-kerulo	mg/l (mg/l)	1783	1882	0.00%
3022756	s-kerulo	g/l (mg/l)	1123	1181	0.00%
3022756	s-kerulo	— (—)	350	383	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Cirrhosis of liver, NAS

355

47.10

307.65

1.1

1.0

285.22

288.22

mg/l

0.13

322

Fibrosis and cirrhosis of liver

453

54.10

307.65

1.1

1.0

291.93

292.81

mg/l

0.04

406

Abnormal findings on examination of blood, without diagnosis

692

1099

5.92

307.65

1.1

294.66

281.77

mg/l

3.38

639

978

Alcoholic liver disease

353

127

30.27

307.65

1.1

1.0

285.88

278.57

mg/l

0.47

316

115

Abnormal serum enzyme levels

550

703

7.90

307.65

1.1

294.57

279.70

mg/l

3.25

516

627

Nonalcoholic fatty liver disease

560

256

25.17

307.65

1.1

1.0

286.26

290.21

mg/l

0.30

488

231

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

657

289

25.29

307.65

1.1

1.0

289.12

281.07

mg/l

0.91

593

257

Diseases of liver

1560

512

33.46

307.65

1.1

1.0

293.05

283.45

mg/l

2.01

1377

467

Other diseases of liver

831

270

34.15

307.65

1.1

1.0

294.12

288.52

mg/l

0.50

720

249

Oesophageal varices

211

24.96

290.92

1.1

1.0

284.42

286.72

mg/l

0.08

195

Chronic hepatitis, not elsewhere classified

166

48.51

282.04

1.1

283.89

300.50

mg/l

0.68

147

Any gastric operation

738

792

4.72

241.64

1.1

287.06

657.66

mg/l

0.50

663

720

GASTRO-related operations

738

792

4.72

241.64

1.1

287.06

657.66

mg/l

0.50

663

720

Ascites

213

151

15.06

236.44

1.1

1.0

298.05

290.15

mg/l

0.43

191

134

Other inflammatory liver diseases

175

20.06

224.58

1.1

1.0

299.66

287.42

mg/l

0.76

165

Gastrointestinal diseases

510

463

5.57

196.69

1.1

287.48

903.44

mg/l

0.50

465

432

Hepatic failure, not elsewhere classified

126

34.43

196.57

1.1

294.40

296.46

mg/l

0.05

118

Alcohol use disorder, Swedish definition

572

1499

3.54

162.49

1.1

283.76

284.44

mg/l

0.07

510

1357

591

1594

3.39

156.43

1.1

284.13

284.01

mg/l

0.01

527

1439

602

1648

3.26

148.29

1.1

284.02

284.82

mg/l

0.08

537

1488

Abnormal results of function studies

184

245

7.85

130.71

1.2

1.0

298.62

286.40

mg/l

0.91

147

217

Anaemias

260

273

6.31

128.03

1.1

299.83

284.88

mg/l

1.41

232

256

Diseases of oesophagus, stomach and duodenum

861

2052

2.53

121.40

1.1

286.33

434.73

mg/l

0.53

761

1865

Autoimmune diseases excluding thyroid diseases

838

1819

2.53

115.37

1.1

292.22

447.72

mg/l

0.47

757

1648

Autoimmune diseases excluding thyroid diseases, strict definition

812

1769

2.53

111.93

1.1

291.47

452.11

mg/l

0.48

734

1601

Extrapyramidal and movement disorders

353

955

3.75

111.76

1.1

282.50

291.77

mg/l

1.56

321

849

Primary biliary cholangitis (PBC)

22.28

105.05

1.1

326.09

295.06

mg/l

1.64

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

766

2190

2.43

103.61

1.1

299.31

423.27

mg/l

0.45

687

1973

Autoimmune diseases related-to ILD

689

2412

2.46

100.93

1.1

294.79

411.87

mg/l

0.47

622

2162

Autoimmune diseases

838

1829

2.34

96.44

1.1

287.90

446.90

mg/l

0.49

750

1658

Type 2 diabetes, wide definition

592

1447

2.64

92.88

1.1

1.0

289.34

495.04

mg/l

0.51

512

1306

Disorders of gallbladder, biliary tract and pancreas

743

1994

2.37

92.75

1.1

294.04

439.22

mg/l

0.48

668

1787

Endocrine, nutritional and metabolic diseases

631

1226

2.62

91.14

1.1

284.71

526.82

mg/l

0.52

567

1127

Inflammatory bowel disease treatment related agents

865

2188

2.22

90.98

1.1

291.88

424.43

mg/l

0.48

789

1956

Examination and observation for other reasons

458

873

3.06

90.51

1.1

295.98

286.35

mg/l

1.39

427

792

ILD medications

854

2088

2.23

89.62

1.1

290.23

430.83

mg/l

0.49

775

1870

Cholangitis (primary sclerosing, PSC)

110

127

9.00

87.88

1.0

307.24

287.14

mg/l

1.11

100

107

ILD medications: immunosuppressive drugs

528

1908

2.59

87.77

1.1

292.49

443.53

mg/l

0.48

490

1713

Used for control exclusion in common control thyroid runs

778

1704

2.32

87.47

1.1

286.16

458.22

mg/l

0.50

698

1541

Type 2 diabetes

732

1843

2.34

87.09

1.1

288.34

453.07

mg/l

0.52

648

1664

Medical observation and evaluation for suspected diseases and conditions

496

876

2.92

86.81

1.1

281.49

286.19

mg/l

0.62

439

795

Substance abuse, excluding more controls

461

1433

2.77

85.38

1.1

287.28

287.40

mg/l

0.01

406

1301

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

494

1720

2.59

81.45

1.1

1.0

295.59

462.67

mg/l

0.48

437

1536

Anxiety disorders, excluding more controls

633

1742

2.38

80.91

1.1

292.94

291.47

mg/l

0.17

562

1573

First line medication for Crohn's disease

819

2048

2.17

80.85

1.1

289.70

434.32

mg/l

0.50

744

1831

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

700

1850

2.29

80.79

1.1

287.32

450.33

mg/l

0.52

625

1674

Heart failure, not strict

548

1486

2.52

80.10

1.1

301.41

484.47

mg/l

0.44

490

1322

Condition for Implicit Sepsis (Organ dysfunction codes)

628

1899

2.35

79.67

1.1

291.71

443.65

mg/l

0.48

565

1697

Diabetes mellitus

750

1999

2.21

78.44

1.1

288.53

438.85

mg/l

0.51

664

1808

Diabetes, varying definitions

747

1998

2.21

78.09

1.1

288.45

438.95

mg/l

0.51

660

1808

Symptoms and signs involving the digestive system and abdomen

712

1574

2.28

76.87

1.1

284.79

287.68

mg/l

0.40

640

1428

Any reimbursement code in KELA

461

820

2.84

76.56

1.1

285.53

287.36

mg/l

0.16

420

743

Tramadol

598

1547

2.39

76.06

1.1

296.22

481.29

mg/l

0.48

534

1396

ILD medications: prednisolone, methylprednisolone, prednisone

782

2046

2.15

75.94

1.1

290.08

433.67

mg/l

0.49

705

1833

Implicit bacterial Sepsis

305

838

3.26

75.91

1.1

1.0

304.21

284.63

mg/l

3.27

275

745

Diabetes, insulin treatment (Kela reimbursement)

723

2010

2.19

74.63

1.1

287.38

438.00

mg/l

0.52

645

1810

Dipeptidyl peptidase 4 (DPP-4) inhibitors

389

1110

2.83

74.13

1.1

281.73

289.24

mg/l

1.10

339

991

Implicit Sepsis

540

1698

2.42

74.02

1.1

296.18

285.78

mg/l

2.01

485

1515

Type 2 diabetes, strict (exclude DM1)

672

1774

2.24

72.80

1.1

284.99

459.37

mg/l

0.53

599

1603

Type 2 diabetes, definitions combined

669

1764

2.24

72.67

1.1

284.83

460.92

mg/l

0.54

596

1593

Insulin medication

437

1415

2.62

72.67

1.1

295.19

286.43

mg/l

1.38

379

1279

Metabolic disorders

689

1926

2.20

72.14

1.1

293.63

443.37

mg/l

0.48

620

1734

General symptoms and signs

773

1822

2.14

71.77

1.1

288.72

452.12

mg/l

0.50

706

1629

Other (not insulin) diabetes medications

685

1856

2.20

71.72

1.1

284.52

451.95

mg/l

0.54

607

1677

Diabetes medication

740

2068

2.13

71.71

1.1

289.30

433.93

mg/l

0.51

657

1870

Hernia of abdominal wall, postoperative

131

231

5.74

70.72

1.0

1.1

292.23

283.88

mg/l

0.54

118

208

Type 2 diabetes, definitions combined, including avohilmo

669

1771

2.21

70.48

1.1

286.61

459.47

mg/l

0.53

596

1601

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

263

339

3.92

70.25

1.1

286.14

287.25

mg/l

0.06

240

310

Hepatocellular carcinoma, including Hilmo

12.60

70.06

1.0

279.30

291.98

mg/l

0.45

Anxiety disorders

686

2249

2.14

69.54

1.1

293.14

420.56

mg/l

0.48

611

2027

Budesonide

170

384

4.52

69.18

1.1

297.78

284.95

mg/l

1.12

152

349

Dystonia

101

141

7.46

68.92

1.1

1.0

285.96

289.50

mg/l

0.15

125

Neurotic, stress-related and somatoform disorders

680

2242

2.14

68.72

1.1

292.68

420.92

mg/l

0.48

606

2022

Noninfective enteritis and colitis

394

1511

2.63

68.54

1.1

288.41

287.29

mg/l

0.10

358

1357

Mood disorders, excluding more controls

661

1816

2.19

68.08

1.1

740.76

291.83

mg/l

0.49

589

1642

Symptoms and signs involving the nervous and musculoskeletal systems

434

1758

2.49

67.43

1.1

283.16

292.66

mg/l

1.91

415

1557

Diseases of the digestive system

348

1259

2.78

67.34

1.1

289.01

287.81

mg/l

0.10

312

1125

Nutritional anaemias

358

1273

2.73

66.87

1.1

304.17

292.63

mg/l

1.86

311

1142

Bacterial Sepsis

332

996

2.87

66.19

1.1

303.34

284.00

mg/l

3.58

299

892

Inflammatory bowel disease

303

1038

2.96

65.72

1.1

288.53

285.47

mg/l

0.26

277

937

Substance abuse

461

1816

2.40

65.70

1.1

287.28

283.63

mg/l

0.48

406

1650

Chronic gastritis

206

556

3.75

65.65

1.1

286.49

293.33

mg/l

0.53

170

497

Iron deficiency anaemia

318

1113

2.84

64.20

1.1

305.78

292.49

mg/l

2.10

277

995

Gastro-oesophageal reflux disease

476

1757

2.35

63.63

1.1

285.29

459.31

mg/l

0.53

407

1598

Mental and behavioural disorders due to psychoactive substance use

468

1855

2.36

63.56

1.1

287.17

283.73

mg/l

0.45

413

1681

Unspecified jaundice

9.16

63.41

1.1

1.0

318.50

287.97

mg/l

1.47

5-aminosalicylic acid

219

634

3.50

62.96

1.1

286.92

283.59

mg/l

0.24

197

574

Cholangitis (primary sclerosing, PSC), with reimbursement 202

14.61

62.87

1.1

1.0

312.92

293.39

mg/l

0.62

Insulin, intermediate and long-acting

405

1594

2.49

62.68

1.1

296.15

283.58

mg/l

2.34

353

1438

Renal failure

315

984

2.85

62.62

1.1

1.0

302.04

284.84

mg/l

3.15

289

875

Depression medications

244

328

3.77

62.17

1.1

289.81

279.11

mg/l

0.85

220

304

Anxiety (asthma-related co-morbidities)

479

1591

2.35

62.04

1.1

293.56

290.29

mg/l

0.39

430

1441

IBD patients in KELA-register

243

761

3.24

61.65

1.1

285.61

284.75

mg/l

0.06

221

690

Oral corticosteroids

717

2108

2.03

61.08

1.1

291.68

429.88

mg/l

0.48

650

1882

Other disorders of fluid, electrolyte and acid-base balance

236

690

3.29

60.96

1.1

1.0

296.50

290.79

mg/l

0.35

207

612

Mental and behavioural disorders due to alcohol, excluding acute intoxication

360

1395

2.59

60.91

1.1

282.89

282.31

mg/l

0.05

316

1265

Inflammatory bowel disease, strict (require KELA)

243

768

3.21

60.73

1.1

285.61

285.00

mg/l

0.04

221

696

GI-bleeding

238

745

3.23

60.27

1.1

1.0

295.93

286.31

mg/l

0.98

213

671

Insulin, combination of fast acting with intermediate-acting or long-acting

437

1695

2.37

60.25

1.1

295.19

284.18

mg/l

2.03

379

1527

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

359

837

2.73

60.11

1.1

293.76

291.10

mg/l

0.21

328

762

Other diseases of the digestive system

240

759

3.19

59.77

1.1

1.0

295.03

287.01

mg/l

0.79

216

683

Other nutritional deficiencies

495

2103

2.23

59.49

1.1

294.44

429.33

mg/l

0.48

423

1917

Aplastic and other anaemias

310

1050

2.77

59.24

1.1

1.0

296.74

289.89

mg/l

0.76

276

937

Biguanides

641

1886

2.08

58.98

1.1

283.97

450.62

mg/l

0.54

568

1702

Other and unspecified anaemias

291

981

2.85

58.80

1.1

1.0

298.41

289.55

mg/l

1.13

259

873

Alcohol use disorder, ICD-based

337

1294

2.63

58.78

1.1

283.58

282.05

mg/l

0.14

297

1167

Cholelithiasis, broad definition with cholecystitis

571

1794

2.15

58.65

1.1

294.24

458.06

mg/l

0.49

517

1605

Other extrapyramidal and movement disorders in other diseases

204

594

3.48

58.15

1.1

1.0

281.70

290.29

mg/l

0.96

186

535

Antihypertensive medication - note that there are other indications

456

999

2.43

57.97

1.1

289.77

288.23

mg/l

0.13

413

913

Acute renal failure

180

484

3.77

57.81

1.1

1.0

304.91

282.70

mg/l

2.82

167

428

Other septicaemia

266

871

2.96

57.75

1.1

304.11

285.53

mg/l

2.42

241

778

Mental and behavioural disorders due to alcohol

394

1573

2.43

57.68

1.1

283.80

282.67

mg/l

0.11

348

1425

Spasmodic torticollis

9.93

57.31

1.1

280.28

293.87

mg/l

0.56

Mood [affective] disorders

717

2380

1.96

57.00

1.1

704.41

289.86

mg/l

0.50

643

2144

Cholelithiasis

550

1768

2.16

57.00

1.1

293.14

461.00

mg/l

0.50

497

1582

Other anaemias

291

995

2.80

56.98

1.1

1.0

298.41

288.87

mg/l

1.26

259

887

Explicit Sepsis

301

1027

2.76

56.95

1.1

303.68

286.45

mg/l

2.43

271

913

Hypertensive diseases (excluding secondary)

407

946

2.52

56.94

1.1

290.70

288.13

mg/l

0.25

362

860

Depression

682

2340

1.99

56.61

1.1

724.55

289.59

mg/l

0.50

611

2108

General examination and investigation of persons without complaint and reported diagnosis

419

876

2.51

56.47

1.1

289.22

286.19

mg/l

0.30

380

795

Other gastritis (incl. Duodenitis)

186

520

3.62

56.40

1.1

1.0

283.45

289.00

mg/l

0.43

163

470

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

129

6.94

56.09

1.1

1.0

282.80

287.36

mg/l

0.17

114

Mood disorders

715

2384

1.95

55.85

1.1

705.73

289.82

mg/l

0.50

641

2148

Heart failure and antihypertensive medication

185

309

3.96

55.65

1.0

1.1

305.62

285.30

mg/l

2.42

165

280

Other bacterial diseases

693

2255

1.96

54.65

1.1

300.02

416.84

mg/l

0.43

626

2025

Obesity and other hyperalimentation

463

2044

2.20

53.88

1.1

295.13

433.21

mg/l

0.48

392

1866

Septicaemia

290

1003

2.73

53.71

1.1

1.0

303.89

284.44

mg/l

2.86

260

891

Fever of other and unknown origin

385

1445

2.39

53.65

1.1

298.70

287.77

mg/l

1.49

354

1289

All anxiety disorders

486

1773

2.18

53.37

1.1

293.62

287.64

mg/l

0.91

436

1605

Malaise and fatigue

350

1132

2.51

52.95

1.1

293.98

289.20

mg/l

0.41

321

996

Obesity

458

2038

2.18

52.48

1.1

295.50

290.94

mg/l

0.63

387

1860

Any mental disorder

714

1844

1.95

52.17

1.1

285.57

292.07

mg/l

1.25

637

1666

Ulcerative colitis

231

781

2.99

51.46

1.1

287.12

284.96

mg/l

0.14

209

705

Other bacterial diseases

632

2166

1.97

51.41

1.1

301.75

422.75

mg/l

0.42

569

1944

Continuous positive airway pressure

140

278

4.29

51.05

1.0

1.1

281.67

285.05

mg/l

0.21

117

268

ILD medications: azathioprine

157

420

3.80

50.94

1.1

1.0

284.47

285.72

mg/l

0.07

142

383

Azathioprine

157

422

3.78

50.59

1.1

284.47

285.16

mg/l

0.04

142

383

Cardiovascular diseases (excluding rheumatic etc)

476

1250

2.20

49.71

1.1

294.13

286.77

mg/l

0.96

431

1141

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

177

522

3.45

49.63

1.1

281.62

284.56

mg/l

0.19

159

474

Other antidepressants

666

1753

1.96

49.56

1.1

285.50

456.57

mg/l

0.52

599

1594

Other and unspecified iron deficiency

246

878

2.83

49.50

1.1

1.0

310.59

292.48

mg/l

2.93

214

789

Neurological diseases, wide definition

236

368

3.24

48.91

1.1

1.0

287.92

290.70

mg/l

0.16

213

345

Other special examinations and investigations of persons without complaint or reported diagnosis

409

876

2.38

48.87

1.1

283.13

286.19

mg/l

0.29

374

795

Ulcerative colitis (strict definition, require KELA)

180

542

3.37

48.84

1.1

283.35

283.89

mg/l

0.03

162

492

Hypothyroidism (congenital or acquired)

188

291

3.68

48.74

1.1

1.0

294.79

283.79

mg/l

0.78

161

271

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

189

588

3.26

48.63

1.1

282.15

284.66

mg/l

0.17

170

532

Neurological diseases

581

1435

2.04

48.53

1.1

284.07

292.52

mg/l

1.62

523

1292

Abdominal and pelvic pain

621

1574

1.99

48.35

1.1

284.05

287.68

mg/l

0.53

565

1428

Opioids

650

1751

1.94

47.31

1.1

289.88

457.01

mg/l

0.49

592

1580

Hypothyroidism and >3 levothyroxin purchases

184

288

3.64

47.08

1.1

1.0

295.88

284.35

mg/l

0.82

158

268

Hypothyroidism, levothyroxine purchases

184

288

3.64

47.08

1.1

1.0

295.88

284.35

mg/l

0.82

158

268

Nausea and vomiting

191

596

3.17

46.88

1.1

294.98

289.42

mg/l

0.38

169

536

Reimbursement for rheumatic diseases

398

1818

2.19

46.59

1.1

296.36

455.71

mg/l

0.48

360

1618

Other diseases of intestines

703

2158

1.86

46.51

1.1

291.77

424.24

mg/l

0.49

629

1968

Second line medication for Crohn's disease

416

1960

2.14

45.52

1.1

288.21

289.73

mg/l

0.15

384

1756

Hypertension, essential

533

1498

2.02

44.89

1.1

288.90

483.56

mg/l

0.50

471

1361

Ulcerative colitis (strict definition, all Crohn cases excluded)

153

439

3.54

44.82

1.1

285.49

283.64

mg/l

0.10

139

398

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

228

832

2.77

44.18

1.0

1.1

288.36

288.16

mg/l

0.01

202

749

Glucagon-like peptide-1 (GLP-1) analogues

228

832

2.77

44.18

1.0

1.1

288.36

288.16

mg/l

0.01

202

749

Ulcerative colitis, NAS

148

420

3.58

44.10

1.1

282.93

285.20

mg/l

0.12

134

384

Obesity due to excess calories

350

1561

2.26

44.02

1.1

294.21

290.62

mg/l

0.41

300

1423

Persons encountering health services for other counselling and medical advice, not elsewhere classified

712

2143

1.81

43.02

1.1

289.01

429.26

mg/l

0.51

649

1916

Certain infectious and parasitic diseases

633

1681

1.89

42.84

1.1

294.12

461.58

mg/l

0.47

579

1512

Abnormalities of breathing

594

1823

1.90

42.25

1.1

291.39

450.62

mg/l

0.49

533

1650

Mucosal proctocolitis

140

396

3.60

41.96

1.1

291.91

285.94

mg/l

0.36

126

360

Dental caries

202

680

2.88

41.91

1.0

1.1

291.19

283.77

mg/l

0.50

180

623

Psychiatric diseases

621

1663

1.88

41.01

1.1

284.69

290.73

mg/l

1.01

557

1502

210

4.67

40.87

1.1

290.62

283.88

mg/l

0.24

191

Hypertension

529

1530

1.96

40.86

1.1

291.24

480.39

mg/l

0.49

467

1387

Persons encountering health services in other circumstances, wide

735

2143

1.77

40.75

1.1

284.25

429.26

mg/l

0.53

667

1916

Persons encountering health services for examination and investigation

389

876

2.24

40.70

1.1

284.24

286.19

mg/l

0.17

352

795

Hypertensive diseases

529

1533

1.96

40.66

1.1

291.24

479.88

mg/l

0.49

467

1390

Chronic kidney disease

184

613

2.97

40.49

1.1

1.0

301.48

284.54

mg/l

1.74

166

543

Oedema, not elsewhere classified

209

757

2.74

39.89

1.1

291.77

290.07

mg/l

0.12

187

668

Infections, IBD-co-morbidities

119

207

4.15

39.44

1.1

1.0

290.83

291.38

mg/l

0.02

106

192

Other soft tissue disorders, not elsewhere classified

596

1893

1.85

39.37

1.1

294.21

289.71

mg/l

0.60

527

1718

Heart failure,strict

301

904

2.36

39.15

1.0

1.1

309.68

280.95

mg/l

7.70

275

802

Selective serotonin reuptake inhibitors

619

1761

1.84

39.04

1.1

284.17

455.52

mg/l

0.52

544

1602

Cholecystectomy

442

1931

1.98

38.78

1.0

1.1

294.41

450.06

mg/l

0.50

399

1718

Headache

423

1676

2.03

38.74

1.1

287.92

466.41

mg/l

0.51

388

1506

Pain in joint

383

1145

2.14

38.69

1.0

1.1

290.82

287.78

mg/l

0.30

340

1039

Bleeding

509

1912

1.90

38.03

1.1

296.18

287.47

mg/l

1.65

452

1716

Cardiovascular diseases

428

1116

2.07

37.92

1.1

290.82

286.54

mg/l

0.40

389

1021

Hepatocellular carcinoma

11.02

37.80

1.0

278.75

289.59

mg/l

0.26

Caries of dentine

181

618

2.88

37.58

1.0

290.52

283.34

mg/l

0.43

159

564

6-mercaptopurine

6.75

36.34

1.1

277.38

288.24

mg/l

0.38

Benzodiazepine use

627

2466

1.76

36.14

1.1

291.92

410.29

mg/l

0.49

551

2227

Bacterial infection, other or unspecified

341

1364

2.13

35.91

1.1

308.38

284.88

mg/l

4.64

308

1213

Other heart diseases

328

975

2.21

35.90

1.0

1.1

297.68

288.02

mg/l

1.16

295

891

Hypokalaemia

101

254

4.03

35.86

1.1

1.0

286.32

290.22

mg/l

0.16

228

Renal tubulo-interstitial diseases

529

2159

1.83

35.59

1.1

298.18

428.88

mg/l

0.46

483

1928

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

585

2119

1.77

34.41

1.1

292.68

430.65

mg/l

0.49

525

1903

All kidney diseases

605

2374

1.75

34.27

1.1

295.04

415.44

mg/l

0.48

548

2132

Codeine

566

1706

1.81

34.18

1.1

288.79

462.23

mg/l

0.50

511

1540

Other anxiety disorders

331

1381

2.09

33.55

1.1

292.55

288.13

mg/l

0.46

299

1251

Malignant neoplasm of liver and intrahepatic bile ducts

8.44

33.53

1.0

278.84

293.49

mg/l

0.42

Irritable bowel syndrome

199

784

2.56

33.22

1.1

284.99

294.54

mg/l

0.91

170

711

Non-invasive ventilation

141

408

3.11

33.01

1.0

1.1

305.84

289.30

mg/l

1.27

122

391

Bacterial infection, other or unspecified

309

1265

2.13

33.01

1.1

309.73

285.23

mg/l

4.33

277

1128

Diarrhoea and gastroenteritis of presumed infectious origin

624

2407

1.72

32.84

1.1

296.17

412.39

mg/l

0.46

563

2162

Alcohol dependence

196

774

2.56

32.59

1.1

289.63

279.80

mg/l

0.98

176

705

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

6.17

32.43

1.1

1.0

287.12

287.97

mg/l

0.02

Hypothyroidism, strict autoimmune

410

1391

1.95

32.38

1.1

295.54

500.60

mg/l

0.48

354

1256

Depression or dysthymia

402

1120

1.99

32.35

1.1

282.98

290.97

mg/l

1.07

358

1022

Diarrhoea and gastroenteritis of presumed infectious origin

441

2159

1.85

31.63

1.1

298.03

287.38

mg/l

2.00

406

1940

Heart failure, strict

314

1052

2.12

31.58

1.0

1.1

308.74

282.57

mg/l

6.96

287

927

L04AX Other immunosuppressants

371

1920

1.94

31.52

1.1

289.41

289.83

mg/l

0.04

341

1724

Intestinal infectious diseases

695

2400

1.66

31.47

1.1

296.16

412.45

mg/l

0.46

628

2155

Disorders of thyroid, IBD co-morbidities

118

237

3.53

31.40

1.0

303.99

299.98

mg/l

0.18

108

220

Insulin, fast-acting

240

1057

2.29

31.26

1.1

306.50

281.74

mg/l

4.34

208

952

Functional dyspepsia

179

691

2.61

31.19

1.1

292.75

293.36

mg/l

0.03

155

623

Symptoms and signs involving the circulatory and respiratory systems

624

1830

1.71

30.86

1.1

287.50

449.67

mg/l

0.51

553

1657

Intestinal infectious diseases

576

2575

1.70

30.44

1.1

296.24

404.00

mg/l

0.46

527

2308

Recurrent or chronic depression

270

863

2.21

30.31

1.1

292.09

290.58

mg/l

0.10

233

794

Constipation

525

2089

1.75

29.79

1.1

287.32

432.27

mg/l

0.52

453

1897

All-cause Heart Failure

302

1034

2.07

28.83

1.0

1.1

308.87

282.64

mg/l

6.78

276

911

Asthma, excluding more controls

452

1285

1.84

28.68

1.1

294.54

518.16

mg/l

0.48

404

1153

Other and unspecified polyneuropathies, also in other diseases

135

472

2.89

28.57

1.1

1.0

292.64

284.86

mg/l

0.52

127

422

Lower back pain or/and sciatica

626

2488

1.65

28.49

1.1

287.88

410.86

mg/l

0.52

560

2236

Symptoms and signs involving cognition, perception, emotional state and behaviour

578

2354

1.68

28.48

1.1

287.51

416.82

mg/l

0.52

514

2120

Low back pain

464

1878

1.78

28.41

1.1

289.94

448.90

mg/l

0.51

417

1697

Parkinson's disease, strict definition, excluding more controls

186

4.08

28.34

1.0

1.1

278.94

301.07

mg/l

1.96

164

Sleep apnoea

566

2175

1.69

28.29

1.0

1.1

288.66

426.18

mg/l

0.51

507

1958

Pain (limb, back, neck, head abdominally)

436

1181

1.86

28.09

1.1

282.80

287.05

mg/l

0.50

396

1070

All chronic kidney diseases

310

1272

2.00

27.85

1.1

300.50

285.73

mg/l

2.40

282

1129

Polyneuropathies and other disorders of the peripheral nervous system

150

563

2.69

27.75

1.1

1.0

297.43

285.20

mg/l

1.00

141

504

Dyspnoea

523

2280

1.70

27.45

1.1

293.45

421.14

mg/l

0.49

472

2045

Disorders of lipoprotein metabolism and other lipidaemias

462

1613

1.78

27.44

1.1

291.86

472.65

mg/l

0.49

410

1447

Insulin, fast-acting or short human

240

1117

2.16

27.38

1.1

306.50

281.77

mg/l

4.36

208

1003

Parkinson's disease, excluding more controls

210

3.80

27.27

1.0

1.1

277.24

300.41

mg/l

2.13

185

Iron deficiency anaemia secondary to blood loss (chronic)

115

379

3.07

27.06

1.1

1.0

294.83

288.36

mg/l

0.37

100

338

Other reaction to severe stress, and adjustment disorders

253

1209

2.11

27.01

1.1

294.85

290.19

mg/l

0.33

224

1094

Pain in throat and chest

507

1775

1.72

26.67

1.1

285.47

455.05

mg/l

0.52

454

1609

Personality disorders, excluding more controls

176

732

2.42

26.27

1.1

292.53

289.61

mg/l

0.20

152

663

Soft tissue disorders

613

1928

1.64

26.17

1.1

288.35

289.08

mg/l

0.07

545

1748

Sleep apnoea, including avohilmo

589

2230

1.64

26.13

1.0

1.1

289.09

422.55

mg/l

0.50

528

2004

Hypothyroidism, drug reimbursement

172

3.72

25.98

1.1

1.0

308.94

290.68

mg/l

1.14

163

Coagulation defects, purpura and other haemorrhagic conditions

144

549

2.65

25.87

1.1

1.0

294.10

287.67

mg/l

0.37

132

491

Dorsalgia

596

1947

1.65

25.85

1.1

286.67

441.81

mg/l

0.52

538

1763

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

181

765

2.37

25.82

1.0

1.1

295.68

292.17

mg/l

0.22

160

692

Gastroduodenal ulcer

138

514

2.69

25.74

1.1

1.0

289.39

286.88

mg/l

0.14

122

461

Follow-up examination after treatment for conditions other than malignant neoplasms

239

728

2.18

25.74

1.0

301.24

289.91

mg/l

1.60

211

656

Cardiac arrhythmias

353

1222

1.88

25.44

1.1

295.51

292.40

mg/l

0.27

312

1115

Benign neoplasm: Colon

293

1442

1.95

25.14

1.0

1.1

289.59

289.83

mg/l

0.02

253

1290

Asthma

459

1375

1.76

25.12

1.1

294.64

504.03

mg/l

0.48

409

1234

Implicit viral Sepsis

127

465

2.75

24.70

1.1

296.80

285.43

mg/l

0.77

114

421

Viral Sepsis

127

465

2.75

24.70

1.1

296.80

285.43

mg/l

0.77

114

421

Other symptoms and signs involving the digestive system and abdomen

111

378

2.96

24.68

1.0

1.1

300.96

297.14

mg/l

0.21

336

Asthma, unspecified (mode), excluding more controls

303

1173

1.94

24.58

1.1

296.28

540.99

mg/l

0.48

270

1053

Systemic connective tissue disorders

209

963

2.18

24.57

1.1

299.91

294.69

mg/l

0.48

192

859

Diseases of arteries, arterioles and capillaries (FINNGEN)

142

365

2.71

24.54

1.1

1.0

296.44

281.20

mg/l

1.24

119

334

Diseases of the skin and subcutaneous tissue

598

1849

1.63

24.53

1.0

1.1

294.32

446.26

mg/l

0.47

537

1661

Pain in limb

463

1816

1.71

24.47

1.1

299.71

290.72

mg/l

1.36

410

1650

Benign neoplasm of colon, rectum, anus and anal canal

341

1611

1.85

24.41

1.0

292.79

473.29

mg/l

0.49

293

1444

Bipolar affective disorders

149

595

2.53

24.37

1.1

1.0

289.61

286.31

mg/l

0.21

137

547

Factors influencing health status and contact with health services

178

357

2.51

24.21

1.1

286.87

283.73

mg/l

0.16

160

324

Crohn disease

114

400

2.89

24.08

1.1

288.77

284.96

mg/l

0.20

105

361

Hypo-osmolality and hyponatraemia

105

351

3.00

23.87

1.1

302.12

291.80

mg/l

0.34

311

Pure hypercholesterolaemia

398

1473

1.77

23.56

1.1

1.0

291.70

491.09

mg/l

0.49

351

1316

Cerebrovascular diseases (FINNGEN)

185

570

2.31

23.16

1.1

1.0

295.05

286.88

mg/l

0.73

168

517

Asthma (only as main-diagnosis), excluding more controls

397

1285

1.77

22.96

1.0

1.1

296.58

518.16

mg/l

0.47

351

1153

Codeine or tramadol medication

652

2295

1.56

22.90

1.1

289.27

420.10

mg/l

0.51

587

2063

Gastric ulcer

100

336

3.00

22.79

1.1

1.0

290.23

288.45

mg/l

0.08

302

Asthma (mode)

445

1394

1.72

22.63

1.1

295.75

501.21

mg/l

0.48

398

1249

Missing teeth due to accident, extraction or parodontitis

326

1702

1.81

22.36

1.1

1.0

292.21

289.84

mg/l

0.24

279

1525

Intracranial trauma

324

1242

1.84

22.19

1.1

1170.63

293.22

mg/l

0.49

298

1121

Atrial fibrillation and flutter

180

509

2.31

22.01

1.0

1901.83

284.21

mg/l

0.50

166

461

Erysipelas

391

1734

1.73

21.99

1.1

297.37

285.13

mg/l

2.03

352

1544

Special screening examination for infectious and parasitic diseases

166

522

2.36

21.98

1.1

281.76

283.59

mg/l

0.11

143

478

Persons encountering health services in other circumstances

237

1188

1.99

21.97

1.1

285.95

289.72

mg/l

0.31

223

1064

Myalgia

158

681

2.34

21.89

1.1

287.25

291.47

mg/l

0.31

138

618

Purpura and other haemorrhagic conditions

106

378

2.84

21.78

1.1

1.0

297.69

287.57

mg/l

0.53

337

Atrial fibrillation and flutter with reimbursement

141

350

2.58

21.70

1.0

1.1

2332.27

280.26

mg/l

0.50

131

317

Other systemic involvement of connective tissue (FG)

160

687

2.31

21.63

1.1

299.49

295.42

mg/l

0.29

148

616

Asthma, unspecified (mode)

306

1251

1.85

21.57

1.1

296.90

526.19

mg/l

0.48

272

1124

Obesity, other/unspecified

222

1104

2.02

21.42

1.1

301.09

291.67

mg/l

1.01

191

1012

Phobic anxiety disorders

112

415

2.72

21.33

1.1

291.55

286.24

mg/l

0.28

102

381

Transplanted organ and tissue status

282

3.13

21.21

1.1

290.41

284.46

mg/l

0.19

254

Neoplasms

471

1511

1.66

21.11

1.1

285.34

477.89

mg/l

0.50

431

1381

Other symptoms and signs involving cognitive functions and awareness

240

1120

1.96

20.88

1.1

1.0

286.71

290.21

mg/l

0.29

212

1007

Exposure to unspecified factor

570

2653

1.55

20.70

1.1

810.98

289.57

mg/l

0.50

514

2383

Use of levodopa decarboxylase inhibitor

281

3.09

20.65

1.0

274.29

287.34

mg/l

1.02

245

Other heart diseases, wide

546

2127

1.57

20.57

1.0

1.1

294.49

287.31

mg/l

1.21

483

1926

Any death

328

1320

1.79

20.50

1.1

296.73

285.37

mg/l

1.45

284

1191

Persons encountering health services for specific procedures and health care

622

2447

1.53

20.47

1.1

294.73

409.16

mg/l

0.47

551

2208

Chronic laryngitis and laryngotracheitis

102

369

2.79

20.42

1.0

1.1

282.78

287.36

mg/l

0.23

335

Dysphagia

129

524

2.48

20.40

1.1

1.0

293.90

289.97

mg/l

0.21

116

467

Asthma (only as main-diagnosis)

403

1375

1.70

20.38

1.0

1.1

297.03

504.03

mg/l

0.47

357

1234

L04AD Calcineurin inhibitors

348

2.86

20.36

1.1

293.60

286.03

mg/l

0.28

315

Other systemic involvement of connective tissue

164

741

2.23

20.35

1.1

1.0

299.26

294.78

mg/l

0.33

152

658

Other symptoms and signs involving the nervous and musculoskeletal systems

246

1291

1.92

20.31

1.1

280.23

293.45

mg/l

2.46

230

1140

Other specific joint derangements/joint disorders

444

1749

1.65

20.27

1.1

289.77

458.29

mg/l

0.50

392

1579

Fall on same level

664

2408

1.51

20.25

1.1

289.05

290.25

mg/l

0.14

589

2180

Erysipelas

294

1437

1.82

20.22

1.1

297.85

281.92

mg/l

2.39

260

1279

Other disorders of skin and subcutaneous tissue, not elsewhere classified

103

377

2.76

20.17

1.1

1.0

303.83

285.32

mg/l

1.29

338

Other noninfective gastroenteritis and colitis

159

712

2.25

20.13

1.0

292.33

288.94

mg/l

0.21

145

639

Acute pancreatitis

118

463

2.57

20.10

1.1

1.0

281.60

285.07

mg/l

0.19

107

416

Sleep disorders (combined)

627

2159

1.53

20.08

1.1

291.81

426.17

mg/l

0.49

561

1941

Dialysis, with operation codes

334

2.88

20.08

1.1

1.0

291.96

281.09

mg/l

0.54

298

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

113

3.98

20.00

1.0

286.00

290.13

mg/l

0.17

103

Hypothyroidism, other/unspecified

491

2027

1.60

19.99

1.1

297.77

438.41

mg/l

0.48

430

1826

Complications of surgical and medical care, not elsewhere classified

548

2424

1.55

19.88

1.1

297.58

412.17

mg/l

0.46

489

2180

Use of hypnotics and sedatives

598

2244

1.53

19.87

1.1

293.19

421.87

mg/l

0.48

533

2015

Hyperkalaemia

104

4.59

19.87

1.1

1.0

316.95

288.84

mg/l

1.54

Oxycodone

202

897

2.05

19.85

1.1

310.64

287.63

mg/l

3.53

176

801

Other diseases of intestine

331

2.87

19.79

1.1

1.0

299.29

286.34

mg/l

0.93

296

Episodal and paroxysmal disorders

623

2081

1.53

19.79

1.1

284.88

292.40

mg/l

1.68

554

1870

Unspecified kidney failure

194

3.49

19.59

1.1

1.0

291.59

286.04

mg/l

0.19

171

Haemorrhage from respiratory passages

183

787

2.11

19.43

1.0

308.26

285.81

mg/l

3.43

160

706

Benign neoplasm of other and ill-defined parts of digestive system

118

472

2.52

19.36

1.1

1.0

291.34

292.25

mg/l

0.04

105

423

Combinations of oral blood glucose lowering drugs

152

680

2.25

19.35

1.0

287.04

285.46

mg/l

0.10

136

609

Hypothyreosis and Thyroxine purchase for inclusion criteria

503

2103

1.57

19.22

1.1

297.66

433.28

mg/l

0.48

441

1896

L04AA Selective immunosuppressants

158

721

2.21

19.20

1.1

293.05

287.30

mg/l

0.36

150

644

Thrombocytopenia, unspecified

183

3.55

19.12

1.1

1.0

290.55

285.94

mg/l

0.13

164

Fibromyalgia

232

3.23

19.10

1.1

1.0

303.34

291.96

mg/l

0.55

210

Complications of medical and surgical care

402

2270

1.63

18.99

1.1

294.49

422.36

mg/l

0.49

352

2043

Excluding asthma or asthma-COPD overlap

452

1391

1.63

18.96

1.1

286.95

501.34

mg/l

0.50

406

1250

Disorders of the thyroid gland

515

2163

1.55

18.67

1.1

297.65

428.42

mg/l

0.47

454

1947

Other disorders of skin and subcutaneous tissue

369

1979

1.66

18.59

1.1

300.17

440.41

mg/l

0.46

324

1777

Other pulmonary diagnosis

450

1391

1.63

18.57

1.1

286.79

501.34

mg/l

0.50

403

1250

Other diseases of pancreas

177

3.55

18.56

1.1

292.83

284.34

mg/l

0.35

157

Concussion

272

1226

1.82

18.51

1.1

1340.25

293.35

mg/l

0.49

251

1105

COPD differential diagnosis

450

1394

1.62

18.41

1.1

288.14

501.21

mg/l

0.50

407

1249

ILD differential diagnosis

450

1394

1.62

18.41

1.1

288.14

501.21

mg/l

0.50

407

1249

Benign neoplasms

554

1994

1.54

18.39

1.1

286.63

435.56

mg/l

0.51

500

1813

Convulsions, not elsewhere classified

145

644

2.24

18.20

1.1

282.79

283.42

mg/l

0.03

129

580

Sciatica+with lumbago

291

1531

1.76

18.01

1.0

1.1

280.93

485.72

mg/l

0.54

259

1379

Parkinson's disease, including avohilmo

332

2.76

17.97

1.0

275.08

286.41

mg/l

0.85

293

Dermatitis and eczema

616

2580

1.48

17.83

1.1

301.67

402.53

mg/l

0.42

562

2309

Polyarthropathies

383

1521

1.65

17.80

1.0

1.1

294.53

484.10

mg/l

0.48

355

1370

Chronic pancreatitis

293

2.86

17.46

1.1

280.33

283.26

mg/l

0.11

262

Finngen Rheumatological endpoints

555

2090

1.51

17.45

1.0

1.1

288.21

431.23

mg/l

0.51

492

1888

Other dorsopathies, not elsewhere classified

566

1964

1.51

17.36

1.1

288.68

440.69

mg/l

0.51

514

1775

Nephropathy related operations

334

2.73

17.25

1.1

1.0

286.92

281.38

mg/l

0.23

299

Complications of procedures, not elsewhere classified

438

2324

1.56

17.07

1.1

296.52

418.48

mg/l

0.47

394

2088

Other functional intestinal disorders

233

1181

1.84

16.87

1.1

296.37

290.33

mg/l

0.52

203

1071

Diseases of the musculoskeletal system and connective tissue

333

977

1.71

16.85

1.1

286.34

289.03

mg/l

0.21

307

894

Other disorders of urethra and urinary system

369

1640

1.63

16.66

1.0

1.1

295.00

479.02

mg/l

0.51

329

1463

Social phobias

242

3.01

16.57

1.1

297.21

285.32

mg/l

0.56

220

Dorsopathies

578

1974

1.49

16.56

1.1

289.93

439.52

mg/l

0.50

523

1785

Other CVD (FINNGEN)

159

3.24

16.19

1.1

289.16

279.03

mg/l

0.40

148

Thiazolidinediones

219

3.09

16.18

1.1

1.0

291.95

285.31

mg/l

0.29

195

Other ulcerative colitis

165

3.45

16.05

1.1

1.0

290.96

287.71

mg/l

0.11

146

Falls/tendency to fall

614

2104

1.46

16.04

1.1

295.56

289.54

mg/l

0.92

547

1908

Pain, not elsewhere classified

155

754

2.07

16.03

1.1

296.90

289.33

mg/l

0.51

144

669

Other external causes of accidental injury

451

1450

1.56

15.91

1.1

293.73

289.91

mg/l

0.41

401

1310

Non-ischemic cardiomyopathy

153

590

2.10

15.83

1.0

306.33

287.83

mg/l

2.25

139

516

Nerve, nerve root and plexus disorders

566

2365

1.47

15.67

1.1

814.67

291.07

mg/l

0.50

507

2120

Abnormalities of heart beat

189

973

1.91

15.67

1.1

282.95

289.66

mg/l

0.66

166

872

Statin medication

417

1493

1.58

15.65

1.1

292.37

486.98

mg/l

0.49

374

1339

Disorder of lipoprotein metabolism, unspecified

264

2.83

15.31

1.1

1.0

297.59

284.54

mg/l

0.75

235

Other diseases of upper respiratory tract

588

2103

1.46

15.30

1.1

287.90

431.07

mg/l

0.52

515

1905

Parkinson's disease

321

2.64

15.23

1.0

277.24

287.14

mg/l

0.69

282

Acute upper respiratory infections

560

2363

1.46

15.22

1.1

296.01

415.99

mg/l

0.47

503

2121

Symptoms and signs involving the urinary system

395

1931

1.56

15.21

1.1

286.01

289.33

mg/l

0.37

343

1738

Vocal cord dysfunction

230

2.87

15.15

1.1

1.0

278.00

288.91

mg/l

0.78

212

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

480

1931

1.51

15.11

1.1

296.35

442.36

mg/l

0.47

436

1735

480

1931

1.51

15.11

1.1

296.35

442.36

mg/l

0.47

436

1735

Other bacterial intestinal infections

107

460

2.34

15.09

1.1

1.0

295.62

286.47

mg/l

0.66

407

Heart failure and coronary heart disease

194

723

1.91

15.08

1.0

1.1

312.64

284.83

mg/l

4.83

178

633

Cholecystitis

283

2.74

15.06

1.1

298.45

287.83

mg/l

0.32

251

Infections of the skin and subcutaneous tissue

332

2051

1.61

15.04

1.1

299.97

284.62

mg/l

2.25

306

1845

Heart failure and bmi 25plus

183

636

1.95

15.03

1.0

1.1

309.36

278.07

mg/l

6.21

170

551

Poisoning by drugs, medicaments and biological substances

163

828

1.98

15.01

1.1

292.78

286.33

mg/l

0.41

138

752

Parkinson's disease, strict definition

295

2.70

15.00

1.0

278.94

285.84

mg/l

0.43

258

Noninfectious colitis NAS

378

2.48

14.87

1.1

297.00

291.79

mg/l

0.24

340

Accidents

445

1450

1.54

14.85

1.1

293.52

289.91

mg/l

0.38

398

1310

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

527

2343

1.47

14.73

1.1

293.24

417.18

mg/l

0.48

482

2100

Abnormal findings on diagnostic imaging of lung

224

1216

1.77

14.55

1.1

1.0

300.59

286.92

mg/l

1.97

206

1084

Other bacterial intestinal infections

130

615

2.13

14.54

1.1

1.0

293.43

285.94

mg/l

0.59

118

544

Other diseases of anus and rectum

146

720

2.03

14.51

1.1

298.04

290.35

mg/l

0.55

136

647

Type 1 diabetes

144

709

2.04

14.42

1.1

308.72

282.48

mg/l

2.84

127

638

Polycystic ovarian syndrome, consortium definition

366

1370

1.59

14.40

1.1

302.28

522.97

mg/l

0.51

328

1218

Hard cardiovascular diseases

453

1792

1.51

14.37

1.1

292.12

454.20

mg/l

0.49

404

1610

Biological medication for rheuma

127

599

2.14

14.36

1.1

280.65

286.49

mg/l

0.37

117

545

Abnormal findings on diagnostic imaging of other body structures

349

2.51

14.32

1.1

1.0

297.73

290.29

mg/l

0.48

311

Hyperkinetic disorders, excluding more controls

278

2.67

14.21

1.1

276.32

286.01

mg/l

0.50

260

Acute upper respiratory infections of multiple and unspecified sites

417

2038

1.52

14.17

1.1

297.34

288.61

mg/l

1.07

369

1836

Disorders of adult personality and behaviour

186

1008

1.86

14.12

1.1

297.08

287.41

mg/l

0.82

160

922

607

2200

1.43

14.09

1.1

296.49

424.17

mg/l

0.47

547

1979

COPD/asthma/ILD related infections

558

1933

1.45

13.87

1.1

295.02

442.33

mg/l

0.47

501

1736

COPD/asthma related infections

558

1933

1.45

13.87

1.1

295.02

442.33

mg/l

0.47

501

1736

Gout

135

576

2.07

13.84

1.0

1.1

296.12

282.74

mg/l

1.13

120

516

Gout, FINNGEN

135

660

2.05

13.75

1.0

296.12

282.08

mg/l

1.24

120

588

Hypothyroidism, strict autoimmune, 3 medication purchases required

432

1945

1.50

13.73

1.1

297.81

446.18

mg/l

0.48

375

1749

Poisoning by medicine

149

758

1.98

13.72

1.1

297.04

286.23

mg/l

0.78

126

692

Influenza and pneumonia

572

2556

1.43

13.71

1.1

294.23

404.46

mg/l

0.47

516

2297

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

311

1931

1.59

13.65

1.1

297.33

293.05

mg/l

0.37

274

1734

Sulfonylureas

132

504

2.09

13.64

1.0

297.30

290.74

mg/l

0.48

117

448

Substance use, excluding alcohol

133

651

2.06

13.64

1.1

299.28

282.44

mg/l

2.01

119

594

Crohn's disease of small intestine

204

2.98

13.63

1.1

1.0

284.65

287.70

mg/l

0.11

185

Asthma-related infections

307

1888

1.60

13.56

1.1

302.07

288.20

mg/l

2.05

271

1703

Asthma, hospital admission 2, infections

307

1888

1.60

13.56

1.1

302.07

288.20

mg/l

2.05

271

1703

Other/unspecified dorsalgia

201

1120

1.79

13.52

1.1

293.35

292.60

mg/l

0.04

184

1000

Acute pancreatitis (for exclusion)

118

554

2.14

13.51

1.1

1.0

281.60

284.74

mg/l

0.18

107

498

Personality disorders

176

955

1.85

13.35

1.1

292.53

288.89

mg/l

0.26

152

871

External causes of morbidity and mortality

362

1156

1.57

13.28

1.1

293.50

289.60

mg/l

0.37

329

1052

Bacterial intestinal infections, IBD co-morbidities

106

481

2.22

13.22

1.1

1.0

296.54

288.39

mg/l

0.57

429

Unspecified urinary incontinence

197

2.97

13.19

1.1

1.0

287.43

295.57

mg/l

0.38

171

Genitourinary diseases

348

1104

1.59

13.18

1.1

278.19

548.64

mg/l

0.51

323

1000

Other blood glucose lowering drugs, excl. Insulins

333

2.48

13.18

1.1

281.91

287.51

mg/l

0.33

294

Parasetamol

445

1509

1.50

13.14

1.0

1.1

291.63

285.10

mg/l

0.76

409

1358

Coeliac disease

335

2.47

13.03

1.2

1.0

283.00

290.89

mg/l

0.39

307

Diverticular disease of intestine

345

1412

1.56

13.02

1.1

1.0

293.98

497.38

mg/l

0.49

295

1282

Elevated blood glucose level

199

2.95

12.97

1.1

279.19

286.55

mg/l

0.26

177

Gout, strict definition

397

2.33

12.94

1.0

293.52

279.72

mg/l

0.93

357

Other and unspecified disorders of skin and subcutaneous tissue

158

3.21

12.88

1.1

1.0

307.24

290.11

mg/l

0.52

140

Bronchitis

566

2532

1.41

12.80

1.1

297.25

405.60

mg/l

0.45

496

2287

Other joint disorders

494

1794

1.46

12.79

1.1

287.15

453.96

mg/l

0.51

441

1619

Sicca syndrome [Sjögren]

208

2.87

12.58

1.1

1.0

304.67

295.95

mg/l

0.43

178

Other diseases of blood and blood-forming organs, wide

129

644

2.02

12.57

1.0

316.58

287.38

mg/l

2.29

112

577

Obesity related asthma

194

1108

1.76

12.44

1.0

1.1

290.57

289.83

mg/l

0.06

169

994

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

181

1014

1.79

12.40

1.0

1.1

295.68

287.26

mg/l

0.69

160

922

Injuries to the head

586

2594

1.39

12.22

1.1

775.74

292.68

mg/l

0.48

537

2319

Diaphragmatic hernia

179

1004

1.79

12.21

1.1

302.06

289.57

mg/l

1.45

158

901

Somatoform disorder

104

485

2.16

12.17

1.1

1.0

285.09

287.79

mg/l

0.13

440

Papulosquamous disorders

212

1251

1.70

12.10

1.0

1.1

295.93

288.23

mg/l

0.63

190

1118

Rheumatism, unspecified

372

2.33

12.07

1.1

306.68

293.94

mg/l

1.01

334

All pneumoniae

538

2565

1.40

12.04

1.1

296.90

404.00

mg/l

0.45

489

2302

Gout, idiopatic and unspecified

116

567

2.06

11.99

1.0

294.62

281.30

mg/l

1.03

102

510

Pneumonia, organism unspecified

480

2360

1.43

11.92

1.1

298.68

413.40

mg/l

0.44

436

2117

Gout, unspecified

458

2.17

11.82

1.0

297.53

282.96

mg/l

1.00

408

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

284

1813

1.57

11.76

1.1

294.08

291.56

mg/l

0.23

250

1625

Symptoms and signs involving the skin and subcutaneous tissue

360

2372

1.49

11.66

1.1

291.10

417.09

mg/l

0.50

334

2118

Hypertensive Heart Disease

102

369

2.17

11.65

1.0

1.1

298.84

284.28

mg/l

1.10

336

Pneumonias (Asthma/COPD co-morbidities)

532

2559

1.40

11.64

1.1

297.68

404.05

mg/l

0.45

483

2298

Collagenous colitis

240

2.65

11.63

1.0

303.95

289.46

mg/l

0.71

217

Symptoms and signs involving speech and voice

171

961

1.79

11.62

1.1

286.31

294.58

mg/l

0.78

152

858

Injuries to the knee and lower leg

623

2531

1.37

11.57

1.1

289.12

407.48

mg/l

0.51

554

2280

Disorders of other endocrine glands

229

1372

1.65

11.57

1.1

297.70

290.61

mg/l

0.54

206

1232

Dizziness and giddiness

369

1971

1.49

11.55

1.1

287.29

443.42

mg/l

0.52

331

1765

Disorders of lens

341

1402

1.52

11.43

1.0

1.1

283.91

501.25

mg/l

0.52

295

1264

Syncope and collapse

202

1017

1.71

11.41

1.1

292.37

287.01

mg/l

0.36

183

893

Irregular menses

252

1236

1.62

11.38

1.1

298.91

545.21

mg/l

0.51

232

1103

Other and unspecified dermatitis

262

1657

1.59

11.38

1.1

299.56

289.03

mg/l

1.19

241

1479

Chronic apical periodontitis

584

2419

1.38

11.36

1.1

292.14

411.45

mg/l

0.49

503

2194

Cerebral cysts

160

3.04

11.35

1.1

276.60

291.33

mg/l

0.65

144

Chronic lower respiratory diseases

640

2511

1.36

11.33

1.1

295.16

405.92

mg/l

0.46

572

2260

Certain disorders involving the immune mechanism

116

580

2.01

11.32

1.1

1.0

302.76

283.75

mg/l

1.61

107

522

Symptoms and signs concerning food and fluid intake

237

2.63

11.31

1.0

278.04

289.92

mg/l

0.62

210

Early onset COPD, excluding more controls

105

506

2.08

11.29

1.0

1.1

304.30

282.49

mg/l

2.09

450

Chronic periodontitis, complicated

276

1757

1.56

11.20

1.1

1.0

293.32

288.34

mg/l

0.55

240

1577

Other intervertebral disc disorders

419

1741

1.45

11.09

1.1

286.65

461.89

mg/l

0.52

375

1570

Benign neoplasm: Colon, unspecified

123

633

1.95

11.05

1.1

1.0

293.67

285.75

mg/l

0.54

566

Chronic periodontitis, including avohilmo

494

2366

1.40

11.01

1.1

290.86

414.40

mg/l

0.49

427

2140

Other CVD

413

2.19

10.99

1.1

1.0

287.74

287.47

mg/l

0.01

370

Asthma, including avohilmo

620

2572

1.36

10.94

1.1

295.67

403.66

mg/l

0.46

553

2315

Generalized anxiety disorder

100

480

2.10

10.91

1.1

1.0

295.60

289.46

mg/l

0.31

440

Diseases of peritoneum

266

2.50

10.88

1.1

1.0

285.92

288.87

mg/l

0.12

241

Ulcer of lower limb, not elsewhere classified

333

2.33

10.85

1.0

294.06

277.60

mg/l

1.03

297

Cough

207

1181

1.66

10.85

1.1

292.42

541.05

mg/l

0.50

185

1066

Percutaneous Coronary Intervention

402

1697

1.46

10.82

1.0

1.1

291.54

464.06

mg/l

0.49

359

1518

Hypertensive heart and/or renal disease

111

406

2.05

10.82

1.0

1.1

298.30

284.20

mg/l

1.17

371

Periodontitis

494

2369

1.40

10.80

1.1

290.68

414.23

mg/l

0.50

427

2143

Excessive, frequent and irregular menstruation

196

623

1.73

10.68

1.1

297.36

782.22

mg/l

0.51

169

557

Shoulder lesions

375

1547

1.47

10.68

1.0

1.1

289.00

290.48

mg/l

0.14

334

1395

238

1484

1.60

10.64

1.1

303.86

288.21

mg/l

1.94

210

1344

Dermatitis

304

2011

1.51

10.63

1.1

304.89

437.10

mg/l

0.43

279

1795

Care involving dialysis

205

2.71

10.63

1.1

1.0

291.72

280.62

mg/l

0.42

187

Coronary revascularization (ANGIO or CABG)

401

1697

1.45

10.60

1.0

1.1

291.85

464.06

mg/l

0.49

358

1518

Emergency coronary revascularization (for ACS)

420

1780

1.44

10.60

1.0

1.1

292.82

456.08

mg/l

0.48

377

1586

Spondylopathies

387

1586

1.46

10.59

1.1

285.26

478.36

mg/l

0.53

341

1432

Other diseases of urinary system

504

2035

1.39

10.57

1.1

291.12

437.69

mg/l

0.50

457

1827

Acute tubulo-interstitial nephritis

286

1613

1.53

10.54

1.1

296.69

292.58

mg/l

0.40

257

1431

Menorrhagia

177

556

1.77

10.53

1.1

304.66

843.12

mg/l

0.50

155

494

Major coronary heart disease event

423

1784

1.43

10.53

1.0

1.1

291.96

455.44

mg/l

0.48

377

1592

Acute alcohol intoxication

137

744

1.85

10.48

1.0

1.1

285.01

281.65

mg/l

0.21

127

677

Psoriasis

159

904

1.77

10.45

1.1

298.19

286.82

mg/l

0.83

143

816

Other diseases of lip and oral mucosa

213

1310

1.63

10.45

1.1

297.66

290.19

mg/l

0.60

192

1174

Osteopathies and chondropathies

276

1676

1.54

10.43

1.0

1.1

298.41

289.89

mg/l

0.84

241

1497

Paralytic ileus and intestinal obstruction

117

604

1.94

10.42

1.1

299.70

289.39

mg/l

0.75

101

541

Speech disturbances, not elsewhere classified

213

2.65

10.40

1.1

1.0

278.88

290.12

mg/l

0.49

189

Pain and other conditions associated with female genital organs and menstrual cycle

113

528

1.98

10.39

1.1

316.11

305.38

mg/l

0.62

102

475

Schizophrenia or delusion, excluding more controls

156

874

1.77

10.39

1.1

287.37

285.47

mg/l

0.12

144

795

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

113

578

1.97

10.39

1.1

297.36

287.80

mg/l

0.50

533

Diagnoses used for exclusion with ILD

130

698

1.87

10.31

1.0

302.66

284.94

mg/l

1.71

120

628

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

514

2553

1.38

10.30

1.1

298.00

404.38

mg/l

0.44

468

2292

Panic disorder

446

2.10

10.21

1.2

1.1

295.25

290.17

mg/l

0.25

407

Spondyloarthritis

100

493

2.04

10.18

1.1

292.55

286.46

mg/l

0.33

446

Chronic sinusitis

222

1391

1.60

10.07

1.1

294.16

291.83

mg/l

0.17

198

1263

Abnormal weight loss

223

2.58

10.03

1.1

1.0

279.96

292.96

mg/l

0.62

199

Migraine

265

1396

1.54

9.99

1.1

286.73

296.97

mg/l

1.47

244

1260

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

267

1698

1.53

9.99

1.0

1.1

279.50

289.83

mg/l

1.56

232

1548

Ischemic heart diseases

422

1790

1.42

9.93

1.0

1.1

288.18

454.88

mg/l

0.50

377

1602

Non-selective monoamine reuptake inhibitors

176

1006

1.69

9.90

1.1

1.0

295.68

585.72

mg/l

0.49

159

904

Glomerular diseases

103

519

2.00

9.90

1.1

1.0

306.11

285.24

mg/l

1.55

469

Acute alcohol intoxication, ICD10

121

644

1.89

9.90

1.0

1.1

284.64

279.68

mg/l

0.32

112

587

Tumor necrosis factor alpha inhibitors

106

541

1.97

9.84

1.1

273.86

286.61

mg/l

1.12

495

Maternal care for other conditions predominantly related to pregnancy

120

626

1.89

9.79

1.1

302.92

304.28

mg/l

0.06

106

562

Injuries to the ankle and foot

380

2376

1.42

9.76

1.1

288.81

289.10

mg/l

0.02

351

2138

Cystitis

412

1728

1.42

9.75

1.1

293.46

468.13

mg/l

0.51

375

1546

Hernia of abdominal wall

222

1405

1.59

9.71

1.1

287.01

285.94

mg/l

0.08

202

1259

Asthma, hospital admissions , main diagnosis only

418

2640

1.40

9.69

1.1

297.83

401.19

mg/l

0.45

372

2381

Specific personality disorders

146

830

1.77

9.65

1.1

293.82

287.65

mg/l

0.44

124

759

Familial hypercholesterolemia

282

2.35

9.61

1.0

292.22

282.73

mg/l

0.49

245

Arthropathies

489

1799

1.38

9.50

1.1

284.18

453.47

mg/l

0.52

447

1624

Glomerular disorders in diseases classified elsewhere

322

2.25

9.46

1.1

1.0

312.72

284.81

mg/l

2.00

289

Suicide or other Intentional self-harm

149

858

1.75

9.43

1.1

297.11

286.51

mg/l

0.80

129

778

L04AC Interleukin inhibitors

190

2.67

9.37

1.0

1.1

284.80

290.88

mg/l

0.17

172

Use of pramipexole

110

579

1.91

9.33

1.0

295.80

290.38

mg/l

0.34

519

Chronic diseases of tonsils and adenoids

423

1915

1.40

9.32

1.1

286.05

443.26

mg/l

0.52

377

1742

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

185

2.68

9.28

1.1

317.48

291.81

mg/l

0.85

171

KRA_PSY_EATING, excluding more controls

167

2.76

9.27

1.1

295.71

310.78

mg/l

0.56

157

Weight loss

244

2.44

9.27

1.1

1.0

277.56

292.55

mg/l

0.78

217

Vascular disorders of the intestines

130

3.03

9.26

1.0

294.79

294.94

mg/l

0.00

113

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

130

640

1.82

9.26

1.1

279.23

283.07

mg/l

0.21

119

590

Cutaneous abscess, furuncle and carbuncle

146

842

1.74

9.20

1.1

315.07

282.41

mg/l

3.27

127

759

Exposure to other specified factors

393

2587

1.40

9.12

1.1

283.21

404.10

mg/l

0.54

349

2338

Diabetic maculopathy, excluding more controls

252

2.40

9.11

1.1

295.15

281.66

mg/l

0.74

223

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

228

2.48

9.11

1.1

315.49

290.72

mg/l

0.89

205

Open wound of head

266

1714

1.50

9.05

1.1

278.63

285.70

mg/l

0.92

246

1533

Asthma (diagnoses ohter than nonallergic)

437

2645

1.37

9.00

1.1

297.02

400.83

mg/l

0.46

388

2391

Diseases of the respiratory system

324

1105

1.47

8.99

1.0

1.1

292.92

557.27

mg/l

0.49

291

994

Type 1 diabetes, wide definition, subgroup 1

111

595

1.87

8.90

1.2

1.1

317.43

281.25

mg/l

3.89

538

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

231

2.45

8.87

1.1

1.0

315.49

298.07

mg/l

0.54

207

Covid-19 confirmed case

170

1033

1.65

8.83

1.0

299.52

288.24

mg/l

1.12

150

929

STROKE

264

1191

1.51

8.82

1.1

285.90

539.92

mg/l

0.51

240

1063

Fracture of shoulder and upper arm

179

1103

1.63

8.76

1.1

300.18

285.79

mg/l

1.76

156

995

Transport accidents

231

1295

1.54

8.74

1.1

285.68

288.53

mg/l

0.25

208

1177

Hypotension

346

2.15

8.72

1.1

1.0

292.56

287.95

mg/l

0.18

305

Enlarged lymph nodes

400

2.06

8.67

1.1

1.0

309.84

285.35

mg/l

1.35

356

Intrahepatic Cholestasis of Pregnancy (ICP)

192

2.58

8.65

1.1

1.0

317.48

300.03

mg/l

0.50

177

Other diseases of hard tissues of teeth

277

954

1.51

8.64

1.0

284.89

289.30

mg/l

0.40

247

867

Nonorganic sleeping disorders, excluding more controls

102

538

1.91

8.63

1.1

1.0

289.56

288.19

mg/l

0.05

494

Unspecified mental disorder

222

1446

1.54

8.62

1.1

291.01

287.23

mg/l

0.33

200

1311

Pleural effusion

336

2.15

8.55

1.0

333.03

281.92

mg/l

2.99

297

Hyperlipidaemia, other/unspecified

160

886

1.67

8.55

1.1

293.02

288.07

mg/l

0.37

139

788

Other headache syndromes

211

1361

1.55

8.53

1.1

1681.01

296.22

mg/l

0.49

191

1215

Gingivitis and periodontal diseases

507

1948

1.35

8.49

1.1

288.36

440.01

mg/l

0.50

438

1764

Explicit bacterial Sepsis

230

2.41

8.45

1.1

1.0

293.41

285.71

mg/l

0.30

206

Intracranial injury

284

1848

1.46

8.38

1.1

1311.93

288.67

mg/l

0.49

258

1662

Other and unspecified effects of external causes

158

957

1.66

8.36

1.0

1.1

283.92

287.91

mg/l

0.28

146

865

Intestinal stricture

140

822

1.71

8.32

1.1

1.0

297.66

287.02

mg/l

0.93

122

736

Other diseases of pleura

185

1019

1.60

8.26

1.0

308.14

285.35

mg/l

2.43

163

905

Ulcerative enterocolitis

3.39

8.24

1.1

1.0

292.48

286.27

mg/l

0.13

Care involving use of rehabilitation procedures

315

2039

1.42

8.20

1.1

297.16

433.94

mg/l

0.46

278

1835

Diseases of arteries, arterioles and capillaries

287

1458

1.46

8.19

1.1

296.87

286.74

mg/l

1.27

244

1317

Mental and behavioural disorders due to tobacco

265

2.29

8.19

1.0

1.1

283.45

288.51

mg/l

0.22

242

Cardiomyopathy

409

2.01

8.18

1.0

1.1

304.03

280.11

mg/l

1.94

371

Provisional assignment of new diseases of uncertain etiology

255

1732

1.47

8.06

1.0

1.1

299.88

290.29

mg/l

1.22

220

1563

Smoking dependency

267

2.27

8.05

1.0

1.1

283.45

287.90

mg/l

0.19

246

Codes for special purposes

255

1733

1.47

8.04

1.0

1.1

299.88

290.35

mg/l

1.21

220

1564

Psoriasis vulgaris

107

589

1.83

7.97

1.1

1.0

297.39

285.28

mg/l

0.61

534

Infections with a predominantly sexual mode of transmission

174

1092

1.60

7.95

1.1

292.21

290.13

mg/l

0.10

149

987

Diseases of oral cavity, salivary glands and jaws

274

954

1.48

7.93

1.0

287.27

289.30

mg/l

0.15

244

867

Senile cataract

285

1200

1.46

7.92

1.1

282.31

536.88

mg/l

0.52

246

1077

Other retinal disorders

280

1507

1.45

7.90

1.1

297.93

287.64

mg/l

1.40

252

1335

Fissure and fistula of anal and rectal regions

116

658

1.77

7.82

1.1

298.72

287.41

mg/l

0.53

101

592

Type 1 diabetes, wide definition

112

629

1.79

7.78

1.2

1.1

316.79

282.23

mg/l

3.66

568

Coronary atherosclerosis

294

1293

1.44

7.76

1.0

1.1

291.43

285.37

mg/l

0.69

264

1145

Disorders of choroid and retina

369

1904

1.38

7.75

1.1

295.69

446.18

mg/l

0.47

334

1693

Presence of cardiac and vascular implants and grafts

181

850

1.59

7.72

1.0

298.77

284.59

mg/l

1.51

163

752

Other or unspecified ileus, impaction or obstruction

405

1.98

7.67

1.1

1.0

298.07

287.49

mg/l

0.59

365

Ischaemic heart disease, wide definition

360

1609

1.39

7.67

1.0

1.1

286.11

474.49

mg/l

0.51

319

1429

Exclusions for E4_PCOS_BROAD

100

549

1.83

7.53

1.1

1.0

308.11

286.06

mg/l

1.87

498

Enterocolitis due to Clostridium difficile

243

2.28

7.51

1.1

1.0

305.61

293.34

mg/l

0.58

215

Cardiomyopathies, Primary/intrinsic

282

2.18

7.48

1.0

1.1

305.11

271.94

mg/l

2.38

259

Behavioural syndromes associated with physiological disturbances and physical factors

466

2502

1.32

7.45

1.1

296.88

407.64

mg/l

0.46

420

2249

Acute sinusitis

271

1754

1.43

7.39

1.1

292.13

289.71

mg/l

0.22

252

1578

Coxibs

134

410

1.73

7.36

1.1

297.04

293.65

mg/l

0.14

120

370

Visual disturbances and blindness

241

1655

1.46

7.30

1.0

1.1

291.82

289.69

mg/l

0.17

216

1483

Injury, poisoning and certain other consequences of external causes

278

962

1.45

7.29

1.0

1.1

293.59

291.31

mg/l

0.16

251

867

Problems related to lifestyle

292

2.14

7.27

1.1

271.86

283.93

mg/l

0.65

267

Kela-code for severe mental illness

191

1256

1.53

7.20

1.1

287.20

284.72

mg/l

0.19

172

1135

Candidiasis

143

881

1.63

7.15

1.1

293.83

292.84

mg/l

0.05

126

787

Crohn's disease of large intestine

145

2.65

7.14

1.0

1.1

293.03

287.47

mg/l

0.14

132

Streptococcal septicaemia

199

2.38

7.10

1.1

1.0

291.95

280.19

mg/l

0.50

176

Injuries to the shoulder and upper arm

410

2482

1.33

7.08

1.1

294.84

406.51

mg/l

0.46

351

2248

Urticaria and erythema

188

1237

1.52

7.07

1.2

1.1

286.68

291.88

mg/l

0.42

167

1112

Spondylopathies (FG)

439

1.90

7.07

1.1

286.92

285.00

mg/l

0.08

400

Diseases of the eye and adnexa

447

1685

1.33

7.04

1.1

287.45

460.25

mg/l

0.50

402

1535

Inflammatory diseases of female pelvic organs

282

1465

1.42

7.03

1.0

1.1

307.59

508.04

mg/l

0.49

253

1301

Unspecified haematuria

179

963

1.54

6.98

1.1

288.39

284.80

mg/l

0.24

161

866

Urticaria

157

996

1.58

6.96

1.2

1.1

287.64

292.40

mg/l

0.32

140

898

Injuries to the thorax

204

1370

1.49

6.94

1.0

1.1

284.09

284.21

mg/l

0.01

182

1232

Diseases of the myoneural junction and muscle

332

2.03

6.89

1.0

281.02

285.62

mg/l

0.17

296

Pruritus

299

2.09

6.86

1.1

1.0

317.00

289.31

mg/l

1.60

269

Migraine without aura

110

640

1.73

6.85

1.1

287.34

294.92

mg/l

0.52

101

589

Other metabolic disorders

355

1.98

6.76

1.1

310.31

292.30

mg/l

0.61

323

Impingement syndrome of shoulder

119

711

1.68

6.73

1.0

1.1

2766.91

285.27

mg/l

0.49

107

639

Cardiomyopathy (excluding other)

295

2.08

6.71

1.0

1.1

305.11

271.63

mg/l

2.43

269

Calcific aortic valvular stenosis

545

1.77

6.68

1.0

311.57

285.53

mg/l

2.56

487

Calcific aortic valvular stenosis, operated

545

1.77

6.68

1.0

311.57

285.53

mg/l

2.56

487

Operations 2 for CAVS

545

1.77

6.68

1.0

311.57

285.53

mg/l

2.56

487

Calcific aortic valvular stenosis, diagnosis (helper)

545

1.77

6.68

1.0

311.57

285.53

mg/l

2.56

487

Acute gastritis

168

2.46

6.67

1.1

1.0

297.53

287.73

mg/l

0.42

151

Disturbance of activity and attention

384

1.93

6.63

1.1

276.70

288.03

mg/l

0.62

353

Calcific aortic valvular stenosis, including rheumatic fever

546

1.76

6.62

1.0

311.57

285.54

mg/l

2.56

488

Vitamin B12 deficiency anaemia

219

2.25

6.56

1.1

1.0

294.78

289.48

mg/l

0.16

190

Benign neoplasm: Stomach

245

2.18

6.56

1.0

292.40

291.50

mg/l

0.03

217

Fracture of lumbar spine and pelvis

507

1.80

6.56

1.1

1.0

290.11

289.13

mg/l

0.04

456

Asthma-related pneumonia or sepsis

156

1001

1.56

6.55

1.1

306.09

289.47

mg/l

1.28

139

896

Asthma, hospital admissions 3, pneumonia

156

1001

1.56

6.55

1.1

306.09

289.47

mg/l

1.28

139

896

Special screening examination for other diseases and disorders

245

2.17

6.53

1.0

1.1

284.57

283.63

mg/l

0.03

219

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

168

1100

1.53

6.51

1.0

1.1

303.32

291.79

mg/l

1.21

159

981

Other respiratory diseases principally affecting the interstitium

395

1.91

6.49

1.0

293.61

285.56

mg/l

0.45

352

Undetermined asthma, excluding more controls

327

2.00

6.42

1.1

291.67

285.41

mg/l

0.27

291

Asthma-related pneumonia

155

998

1.55

6.42

1.1

306.64

289.44

mg/l

1.34

138

893

Sarcoidosis

390

1.91

6.41

1.0

310.82

285.82

mg/l

1.92

354

Other medical care

194

1178

1.48

6.39

1.1

297.26

289.08

mg/l

0.80

170

1047

Benign neoplasm: Caecum

255

2.13

6.34

1.0

279.39

288.72

mg/l

0.44

223

Other acute lower respiratory infections

243

1637

1.42

6.34

1.1

296.00

287.52

mg/l

0.96

212

1476

Disturbances of skin sensation

143

910

1.58

6.31

1.1

285.10

291.25

mg/l

0.57

132

819

Acetic acid derivatives and related substances

128

399

1.67

6.30

1.0

1.1

292.08

294.65

mg/l

0.10

111

359

Other maternal disorders predominantly related to pregnancy

274

1228

1.40

6.30

1.1

306.02

546.10

mg/l

0.49

248

1095

Cerebrovascular diseases

316

1632

1.36

6.25

1.1

1.0

288.89

290.10

mg/l

0.11

287

1445

Disorders of skin appendages

240

1698

1.42

6.25

1.1

292.88

288.42

mg/l

0.31

215

1528

Diseases of pulp and periapical tissues, including avohilmo

509

2060

1.28

6.20

1.1

291.16

288.42

mg/l

0.30

448

1870

Hyperkinetic disorders

414

1.85

6.19

1.1

276.94

286.23

mg/l

0.50

383

Sleep disorders

439

2451

1.30

6.18

1.1

296.01

410.40

mg/l

0.46

392

2202

Abnormal findings on diagnostic imaging of central nervous system

121

2.67

6.16

1.3

1.0

257.69

291.79

mg/l

1.53

104

Sub-endpoint used in defining T1D endpoints

143

901

1.57

6.13

1.1

307.77

281.28

mg/l

2.94

126

817

Umbilical hernia

133

839

1.59

6.11

1.1

1.0

289.47

280.03

mg/l

0.71

118

767

Emotionally unstable personality disorder

390

1.88

6.09

1.1

304.79

292.43

mg/l

0.68

360

Other interstitial pulmonary diseases

348

1.93

6.08

1.0

292.59

285.20

mg/l

0.38

308

Diseases of salivary glands

157

1033

1.53

5.99

1.1

289.96

291.19

mg/l

0.07

143

928

Interstitial lung disease

350

1.92

5.98

1.0

292.59

284.97

mg/l

0.40

310

Interstitial lung disease endpoints

350

1.92

5.98

1.0

292.59

284.97

mg/l

0.40

310

Undetermined asthma

336

1.94

5.98

1.1

291.67

286.79

mg/l

0.20

300

Neuromuscular dysfunction of bladder

242

2.12

5.94

1.1

1.0

300.29

290.15

mg/l

0.42

219

Other abnormal uterine and vaginal bleeding

103

433

1.71

5.94

1.0

1.1

293.76

989.49

mg/l

0.51

388

Diabetic neuropathy

406

1.85

5.93

1.0

1.1

296.32

277.34

mg/l

1.20

362

DVT of lower extremities

445

1.81

5.88

1.1

1.0

293.59

285.62

mg/l

0.46

403

Diseases of the ear and mastoid process

590

2372

1.25

5.85

1.0

1.1

290.70

290.08

mg/l

0.06

531

2138

ILD, hospital admissions 1, main diag only

312

1.97

5.81

1.0

291.89

285.75

mg/l

0.27

275

Erosion of teeth , including avohilmo

134

858

1.57

5.80

1.1

287.29

287.30

mg/l

0.00

119

782

ILD, hospital admissions

347

1.91

5.80

1.0

293.47

285.10

mg/l

0.45

308

Voice disturbances

123

772

1.60

5.80

1.0

1.1

289.01

294.08

mg/l

0.34

109

694

Cervicalgia

581

1.69

5.78

1.1

289.63

291.22

mg/l

0.08

519

Other and unspecified nonorganic psychotic disorders

114

704

1.63

5.75

1.1

289.06

283.36

mg/l

0.36

105

642

Injuries to the abdomen, lower back, lumbar spine and pelvis

175

1175

1.48

5.75

1.1

1.0

287.44

286.77

mg/l

0.04

156

1055

Paroxysmal tachycardia

453

1.72

5.70

1.0

1.1

291.32

286.04

mg/l

0.22

411

Hernia

452

2374

1.28

5.68

1.1

290.93

414.26

mg/l

0.49

406

2134

Atherosclerosis, excluding cerebral and coronary sclerosis

145

746

1.54

5.68

1.1

1.0

302.20

286.56

mg/l

1.39

123

669

Amputation

220

2.15

5.67

1.1

1.0

308.41

282.74

mg/l

0.94

196

Migraine with aura

121

761

1.60

5.66

1.1

291.50

295.81

mg/l

0.25

115

695

Non-rheumatic valve diseases

193

958

1.46

5.65

1.1

304.86

281.77

mg/l

3.84

173

863

Valvular heart disease excluding rheumatic fever

194

965

1.45

5.64

1.1

305.02

281.92

mg/l

3.88

174

870

Carpal tunnel syndrome

279

1814

1.36

5.64

1.1

294.76

292.80

mg/l

0.18

245

1616

Disorders of synovium and tendon

241

1521

1.39

5.63

1.1

295.07

290.56

mg/l

0.40

213

1374

Anti-inflammatory and antirheumatic products, non-steroids

139

442

1.58

5.60

1.0

1.1

291.99

292.04

mg/l

0.00

127

400

Peripheral artery disease

159

842

1.51

5.60

1.1

1.0

298.30

286.29

mg/l

1.00

135

755

Superficial injury of lower leg

122

772

1.59

5.57

1.0

1.1

294.24

289.39

mg/l

0.35

105

695

Thyroiditis, ILD-related definition

303

1.96

5.57

1.1

1.0

323.20

292.72

mg/l

1.50

279

Lumbar disc prolapse

293

1669

1.35

5.56

1.1

285.02

468.45

mg/l

0.53

266

1508

Other problems related to primary support group, including family circumstances

350

1.87

5.52

1.0

1.1

4571.10

291.10

mg/l

0.49

316

Ovarian cyst

159

605

1.52

5.50

1.1

304.40

797.38

mg/l

0.50

141

540

Thyrotoxicosis, other and/or unspecified

552

1.69

5.48

1.0

1.1

303.09

295.28

mg/l

0.47

498

Superficial injury of head

111

690

1.61

5.46

1.1

1.0

284.18

285.73

mg/l

0.08

100

616

Malignant neoplasm of digestive organs

157

827

1.50

5.45

1.1

300.30

285.68

mg/l

1.32

141

742

Visual disturbances

218

1559

1.40

5.44

1.0

1.1

288.59

290.41

mg/l

0.14

196

1403

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

100

2.73

5.44

1.0

305.19

294.26

mg/l

0.25

Polyuria

547

1.69

5.40

1.1

1.0

277.85

287.99

mg/l

0.61

492

Atopic dermatitis

295

1809

1.34

5.39

1.1

300.18

286.96

mg/l

2.14

268

1632

Adalimumab

314

1.92

5.38

1.1

1.0

276.40

289.52

mg/l

0.85

282

Early onset COPD

105

647

1.63

5.37

1.0

1.1

304.30

283.39

mg/l

2.05

576

Rotator cuff syndrome

268

1415

1.36

5.36

1.0

1.1

1383.28

290.28

mg/l

0.50

243

1270

Fracture of lower leg, including ankle

255

1857

1.36

5.35

1.1

286.35

288.95

mg/l

0.19

231

1674

Dental pulpitis, including avohilmo

469

2416

1.26

5.31

1.1

295.25

409.64

mg/l

0.46

423

2180

Assault

483

1.73

5.29

1.1

284.22

279.46

mg/l

0.24

440

Pacemaker

109

652

1.61

5.26

1.0

308.03

285.05

mg/l

2.55

577

Dental caries, including avohilmo

337

1306

1.32

5.24

1.0

285.64

291.58

mg/l

0.77

303

1171

Exclusions for E4_PCOS_CONSORTIUM

343

1642

1.31

5.20

1.1

299.52

477.75

mg/l

0.49

307

1475

Restless leg syndrome

375

1.82

5.20

1.1

1.0

287.84

291.83

mg/l

0.17

337

Cerebral palsy and other paralytic syndromes

325

1.89

5.20

1.1

1.0

296.15

289.42

mg/l

0.26

292

AV-block

295

1.88

5.19

1.0

313.70

279.51

mg/l

2.56

267

Other predominantly sexually transmitted diseases, not elsewhere classified

569

1.66

5.18

1.1

284.10

289.07

mg/l

0.26

520

Other and unspecified urticaria

100

615

1.63

5.18

1.3

1.1

286.98

291.11

mg/l

0.19

553

Ulcerative rectosigmoiditis

256

2.01

5.17

1.1

277.07

285.84

mg/l

0.36

231

Fenamates

250

1.85

5.12

1.1

1.0

286.56

300.18

mg/l

0.94

225

Disorders of parathyroid gland

504

1.69

5.10

1.0

299.50

295.35

mg/l

0.22

444

Other skin changes

481

1.71

5.08

1.1

1.0

289.84

291.39

mg/l

0.07

429

Caries of enamel

442

2534

1.26

5.06

1.1

283.84

406.50

mg/l

0.54

389

2293

Insomnia

423

2437

1.27

5.06

1.1

296.71

411.64

mg/l

0.46

382

2192

Peripheral arterial reconstruction

336

1.85

5.01

1.0

319.81

283.33

mg/l

2.32

298

Other arthritis (FG)

140

937

1.50

5.01

1.1

297.11

288.55

mg/l

0.78

134

839

Liquid cancers, helper endpoint

158

942

1.47

4.99

1.1

305.15

286.40

mg/l

2.19

137

847

Endometriosis

151

592

1.50

4.97

1.1

301.45

809.30

mg/l

0.50

139

527

UC patients in KELA-register (code 208), prior to 1994

123

2.47

4.97

1.1

1.0

303.40

285.73

mg/l

0.53

111

Fracture of foot, except ankle

124

811

1.53

4.96

1.1

282.27

284.76

mg/l

0.14

115

734

Procreative management

182

1066

1.43

4.95

1.2

1.1

296.61

287.52

mg/l

0.55

158

963

Fracture of rib(s), sternum and thoracic spine

128

843

1.52

4.95

1.0

1.1

285.37

281.41

mg/l

0.20

115

756

Thyrotoxicosis

116

748

1.56

4.94

1.0

1.1

300.46

297.66

mg/l

0.15

108

668

Mixed and other personality disorders

255

1.97

4.87

1.1

299.11

286.41

mg/l

0.86

233

Trigger finger

398

1.77

4.86

1.0

1.1

302.41

285.17

mg/l

1.02

359

Dental operations

278

1065

1.34

4.85

1.0

1.1

287.77

292.87

mg/l

0.51

250

957

Epilepsy

135

901

1.50

4.84

1.1

283.29

285.89

mg/l

0.15

124

813

Eating disorder

228

2.03

4.82

1.1

1.0

295.71

304.30

mg/l

0.27

213

Migraine without aura and triptan purchases

520

1.66

4.79

1.1

285.05

299.00

mg/l

1.00

471

Hypocalcemia

3.21

4.78

1.1

302.06

281.94

mg/l

0.38

Disorders of psychological development

392

1.74

4.72

1.1

281.68

281.47

mg/l

0.01

359

Other viral diseases

190

1354

1.40

4.69

1.1

299.46

287.19

mg/l

0.87

177

1231

Propionic acid derivatives

134

442

1.53

4.69

1.1

291.25

292.03

mg/l

0.03

122

400

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

252

1.96

4.68

1.0

288.78

292.12

mg/l

0.11

228

Atopic dermatitis, strict definition with reimbursement

156

1046

1.44

4.64

1.0

1.1

297.37

288.21

mg/l

0.75

146

947

Vitreous haemorrhage

281

1.90

4.63

1.1

1.0

306.38

288.29

mg/l

1.02

253

Acute bronchitis

172

1193

1.42

4.62

1.1

295.30

288.57

mg/l

0.54

147

1067

Lichen ruber planus, wide definition including periferal and oral lichen planus

626

1.59

4.62

1.1

1.0

289.08

289.48

mg/l

0.02

560

Major coronary heart disease event excluding revascularizations

246

1219

1.35

4.61

1.0

1.1

293.21

284.00

mg/l

1.07

224

1080

Adverse effects, not elsewhere classified

611

1.59

4.60

1.1

1.0

284.92

291.84

mg/l

0.45

553

Persistent mood disorders

542

1.63

4.58

1.1

288.32

289.03

mg/l

0.03

486

Infections with a predominantly sexual mode of transmission

203

1378

1.38

4.57

1.1

291.09

288.87

mg/l

0.12

176

1255

Subjective visual disturbances

117

771

1.52

4.55

1.0

1.1

288.09

291.58

mg/l

0.22

104

693

Misadventures to patients during surgical and medical care

399

1.74

4.55

1.1

1.0

297.70

290.95

mg/l

0.29

361

Peripheral artery operations in Hilmo

262

1.92

4.51

1.1

1.0

305.52

282.45

mg/l

0.92

235

Diseases of external ear

149

1034

1.44

4.49

1.0

1.1

293.33

288.05

mg/l

0.38

131

925

Sulfasalazine

125

839

1.49

4.46

1.0

1.1

282.13

287.55

mg/l

0.41

113

752

Postmenopausal bleeding

115

395

1.56

4.46

1.1

1.0

298.82

1063.22

mg/l

0.50

351

Benign neoplasm: Ascending colon

343

1.79

4.44

1.0

287.43

287.20

mg/l

0.01

305

Mycoses

119

792

1.51

4.43

1.1

1.0

299.39

287.12

mg/l

0.96

108

707

Congenital malformations, deformations and chromosomal abnormalities

315

2263

1.28

4.43

1.1

292.48

288.64

mg/l

0.31

282

2045

Colonic or urogenital fistula

124

834

1.49

4.39

1.1

1.0

297.91

286.77

mg/l

0.55

105

752

Caries of dentine, including avohilmo

354

1416

1.28

4.39

1.0

1.1

286.13

290.85

mg/l

0.56

319

1274

Other and unspecified drugs and medicaments

237

1.95

4.39

1.0

289.79

290.82

mg/l

0.03

212

Chronic rhinitis, nasopharyngitis and pharyngitis

149

1039

1.44

4.38

1.0

1.1

295.86

290.75

mg/l

0.31

129

948

Personal history of other diseases and conditions

336

1.79

4.36

1.1

1.0

296.47

295.40

mg/l

0.03

306

Other arthrosis

237

1228

1.34

4.34

1.0

1.1

288.66

531.63

mg/l

0.50

203

1098

Agranulocytosis

302

1.83

4.33

1.1

1.0

336.88

291.64

mg/l

1.65

273

Enthesopathies of lower limb, excluding foot

105

685

1.54

4.30

1.1

287.52

290.58

mg/l

0.16

610

Delirium, not induced by alcohol and other psychoactive substances

253

1.90

4.26

1.1

1.0

279.36

289.72

mg/l

0.44

226

DVT of lower extremities and pulmonary embolism

161

1140

1.41

4.26

1.1

1.0

303.99

287.76

mg/l

1.93

143

1017

Other disorders of bone

642

1.55

4.19

1.1

289.14

286.73

mg/l

0.08

583

Ventral hernia

101

658

1.54

4.18

1.0

284.69

286.07

mg/l

0.07

595

Benign neoplasm: Rectum

463

1.65

4.17

1.0

288.45

288.68

mg/l

0.01

415

Primary hyperparathyroidism

270

1.86

4.16

1.0

299.74

295.24

mg/l

0.18

239

Disorders resulting from impaired renal tubular function

2.55

4.14

1.0

269.78

282.31

mg/l

0.38

Candidiasis

374

1.72

4.10

1.1

1.0

291.25

288.73

mg/l

0.09

336

Hyperparathyroidism

422

1.67

4.09

1.1

1.0

297.21

292.89

mg/l

0.21

372

Volume depletion

181

2.05

4.09

1.1

1.0

324.59

282.30

mg/l

1.69

154

Congenital malformations, deformations and chromosomal abnormalities

286

2127

1.28

4.03

1.1

289.62

288.95

mg/l

0.04

255

1920

Other specified/unspecified arthritis

118

801

1.48

4.03

1.1

301.40

288.90

mg/l

1.23

112

716

Benign neoplasm: Rectum, anus and anal canal

514

1.60

4.02

1.0

1.1

299.07

288.49

mg/l

0.37

463

Benign neoplasm: Sigmoid colon

483

1.62

4.02

1.0

275.54

287.65

mg/l

0.97

430

Other disorders of patella

569

1.57

4.02

1.1

293.91

291.40

mg/l

0.13

512

Congenital malformations and deformations of the musculoskeletal system

360

1.72

4.00

1.0

1.1

299.73

284.40

mg/l

0.42

326

Other enthesopathies

133

926

1.44

3.99

1.0

1.1

2518.68

290.54

mg/l

0.49

119

831

Schizophrenia or delusion

156

1118

1.40

3.98

1.1

287.37

283.93

mg/l

0.24

144

1006

Diseases of middle ear and mastoid

270

1711

1.29

3.98

1.1

1344.24

287.21

mg/l

0.50

252

1542

Other arrhythmias

279

1636

1.29

3.97

1.1

1384.52

288.16

mg/l

0.50

242

1476

Internal derangement of knee

169

1223

1.38

3.95

1.1

292.99

288.28

mg/l

0.32

144

1097

COPD

167

989

1.38

3.89

1.0

300.99

285.31

mg/l

1.87

147

876

Schizophrenia, schizotypal and delusional disorders

156

1123

1.39

3.89

1.1

287.37

284.03

mg/l

0.24

144

1011

Other viral diseases

146

1036

1.41

3.89

1.1

302.53

285.43

mg/l

1.04

134

942

Inflammatory diseases of prostate (prostatitis)

358

1.71

3.88

1.0

1.1

256.46

277.26

mg/l

1.88

327

COPD (mode)

112

592

1.49

3.87

1.0

1.1

310.28

282.88

mg/l

3.08

521

Diabetic retinopathy, excluding more controls

151

597

1.42

3.87

1.0

1.1

297.51

280.42

mg/l

1.80

135

524

Eating disorders

306

1.77

3.86

1.1

1.0

304.39

297.50

mg/l

0.23

281

Mental and behavioural disorders due to opioids

126

2.24

3.84

1.1

315.61

274.24

mg/l

2.09

114

All influenza

109

736

1.48

3.84

1.2

1.1

291.16

282.79

mg/l

0.55

664

Other complications of surgical and medical care, not elsewhere classified

278

1.81

3.83

1.1

1.0

313.81

294.37

mg/l

1.02

249

Other pleural conditions

228

1.89

3.81

1.0

303.91

285.94

mg/l

0.77

198

Other predominantly sexually transmitted diseases, not elsewhere classified

107

722

1.49

3.80

1.1

279.95

287.47

mg/l

0.49

661

Polymyalgia rheumatica

265

1.82

3.76

1.0

313.37

287.82

mg/l

1.46

228

Dilated cardiomyopathy

302

1.76

3.75

1.0

300.81

281.31

mg/l

0.94

271

Heartburn

244

1.85

3.73

1.0

279.74

290.42

mg/l

0.68

219

Conduction disorders

108

591

1.48

3.71

1.0

1.1

299.24

286.17

mg/l

1.04

533

Mixed specific developmental disorders

2.76

3.70

1.2

1.1

269.44

291.16

mg/l

0.45

Injuries to the wrist and hand

469

2695

1.21

3.70

1.1

932.36

290.30

mg/l

0.50

416

2433

Metatarsalgia

245

1.85

3.69

1.0

294.15

289.74

mg/l

0.15

222

Nonorganic sleeping disorders

102

687

1.49

3.67

1.1

289.56

289.07

mg/l

0.02

632

Otitis externa

100

671

1.49

3.66

1.1

296.91

286.35

mg/l

0.74

605

Other spirochaetal diseases

138

985

1.40

3.65

1.1

299.18

290.74

mg/l

0.58

124

881

Assault by bodily force

261

1.81

3.63

1.0

1.1

276.79

279.22

mg/l

0.08

238

Other spirochaetal diseases

136

969

1.41

3.63

1.1

300.39

290.47

mg/l

0.71

122

865

Diseases of pulp and periapical tissues and dental caries

291

1170

1.28

3.63

1.0

286.81

290.24

mg/l

0.33

265

1049

Malignant neoplasm, wide definition for exclusion

412

1978

1.22

3.63

1.1

297.73

436.82

mg/l

0.46

369

1784

Deviated nasal septum

143

1027

1.39

3.62

1.0

1.1

274.79

283.76

mg/l

0.87

126

936

Unspecified fall

213

1603

1.31

3.62

1.1

288.53

288.11

mg/l

0.02

191

1442

Noninflammatory disorders of female genital tract

171

624

1.38

3.61

1.1

306.04

781.85

mg/l

0.50

151

558

Chondropathies

490

1.58

3.60

1.1

289.05

287.21

mg/l

0.04

447

Other disorders of lacrimal gland

151

1100

1.38

3.55

1.1

299.08

293.60

mg/l

0.33

134

978

Metabolic disorder, other/unspecified

10.46

3.54

1.7

1.0

229.00

288.33

mg/l

—

Retention of urine

121

695

1.43

3.49

1.1

288.51

286.37

mg/l

0.12

105

627

Adjustment and management of implanted device

362

1.66

3.48

1.1

1.0

318.13

285.22

mg/l

2.06

327

Psychotic depression

145

2.08

3.47

1.1

287.21

288.01

mg/l

0.02

137

Other contact dermatitis

236

1.83

3.47

1.0

314.47

289.75

mg/l

0.86

212

Other specified and unspecified personality disorders

280

1.76

3.46

1.1

301.02

288.70

mg/l

0.55

255

Fall on and from stairs and steps

111

770

1.45

3.46

1.0

294.53

287.46

mg/l

0.58

693

Disorders of tooth development and eruption

411

1.56

3.44

1.1

301.57

282.20

mg/l

1.00

376

Diabetic nephropathy, excluding more controls

471

1.53

3.43

1.1

324.00

281.32

mg/l

4.99

411

Mycoses

389

2789

1.21

3.41

1.1

290.23

396.22

mg/l

0.50

345

2510

Fentanyl

187

1.93

3.41

1.1

315.68

291.26

mg/l

0.83

165

Other sleep disorders

289

1.74

3.40

1.1

1.0

275.61

288.10

mg/l

0.61

262

Diabetic nephropathy

578

1.51

3.39

1.1

322.65

280.97

mg/l

4.86

517

Alzheimer’s disease, strict definition

356

0.44

3.35

1.0

280.86

294.70

mg/l

0.36

308

Other cataract

171

965

1.34

3.35

1.0

1.1

289.49

290.95

mg/l

0.10

153

865

Alzheimer disease, including avohilmo

484

0.55

3.35

1.0

291.37

291.24

mg/l

0.00

418

Lyme disease

133

959

1.39

3.35

1.1

298.23

290.58

mg/l

0.50

119

856

Lichen planus, including avohilmo

531

1.53

3.35

1.1

1.0

291.44

289.23

mg/l

0.10

474

Disease of hard tissues of teeth, NOS

233

942

1.30

3.33

1.1

1.0

282.56

289.74

mg/l

0.79

206

856

Other female pelvic inflammatory diseases

429

1.59

3.32

1.0

1.1

298.93

300.96

mg/l

0.10

379

Spirochaetal infections, other/unspecified

134

969

1.39

3.32

1.1

298.99

290.43

mg/l

0.59

120

866

Other respiratory disorders and diseases

461

1.57

3.30

1.1

1.0

309.21

286.08

mg/l

1.56

416

Other diseases of the respiratory system

461

1.57

3.30

1.1

1.0

309.21

286.08

mg/l

1.56

416

Other salmonella infections

115

2.19

3.29

1.1

1.0

309.44

286.86

mg/l

0.85

101

Diseases of tongue

149

2.02

3.25

1.1

283.50

289.41

mg/l

0.13

135

Colectomy operation

424

1.59

3.24

1.1

1.0

300.16

288.36

mg/l

0.53

382

Other enthesopathy of foot (+metatarsalgia)

271

1.74

3.24

1.0

294.98

288.68

mg/l

0.25

246

Haemolytic anaemias

2.40

3.23

1.1

1.0

300.80

290.09

mg/l

0.20

Disorders of lacrimal system

179

1356

1.32

3.23

1.1

298.01

295.00

mg/l

0.19

160

1209

Osteoporosis

575

1.48

3.22

1.1

1.0

307.71

298.33

mg/l

0.60

504

Any event in cancer register

427

2095

1.20

3.20

1.1

297.14

429.45

mg/l

0.46

381

1888

Childhood asthma (age<16), excluding more controls

326

1.60

3.20

1.1

289.33

276.82

mg/l

0.38

299

Superficial injury of thorax

426

1.58

3.18

1.0

291.19

284.87

mg/l

0.30

385

Temporomandibular joint disorders, including avohilmo

200

1524

1.30

3.17

1.0

1.1

291.96

296.32

mg/l

0.33

175

1372

Cervical disc disorders

147

1089

1.35

3.15

1.1

276.11

561.79

mg/l

0.53

133

979

Striking against or struck by other objects

160

1200

1.34

3.14

1.1

280.45

281.05

mg/l

0.04

143

1091

Childhood asthma (age<16)

328

1.59

3.14

1.1

289.33

278.24

mg/l

0.32

302

Other and unspecified nerve root and plexus disorders, also in other diseases

637

1.46

3.13

1.1

1.0

287.66

284.35

mg/l

0.19

573

Other salmonella infections

2.26

3.13

1.1

1.0

313.68

285.50

mg/l

1.09

Alzheimer disease

406

0.52

3.12

1.0

273.26

294.14

mg/l

0.82

353

Other chronic obstructive pulmonary disease

155

952

1.34

3.12

1.0

303.63

285.98

mg/l

2.10

135

839

Alzheimer’s disease (Late onset)

305

0.41

3.11

1.0

294.50

296.91

mg/l

—

261

Convalescence

138

2.04

3.11

1.0

292.83

285.39

mg/l

0.21

127

Carcinoma in situ of skin of trunk

2.82

3.09

1.0

291.36

295.12

mg/l

0.05

Atopic dermatitis, strict definition

147

1070

1.35

3.09

1.0

1.1

297.68

289.99

mg/l

0.57

139

978

Allergic asthma (mode), excluding more controls

102

698

1.43

3.08

1.0

1.1

292.13

284.65

mg/l

0.50

634

COPD related to multimorbidity

134

827

1.37

3.07

1.0

300.81

285.38

mg/l

1.62

116

738

Special screening examination for neoplasms

119

2.11

3.04

1.0

1.1

266.39

290.81

mg/l

0.73

107

369

1.60

3.02

1.0

314.44

288.76

mg/l

0.73

331

Spinal stenosis

189

1104

1.30

3.02

1.1

290.62

560.26

mg/l

0.50

164

991

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

473

1.53

2.99

1.0

1.1

315.46

301.69

mg/l

0.83

422

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

131

953

1.36

2.95

1.0

1.1

2486.54

294.00

mg/l

0.49

121

868

Tongue abnormality

155

1.95

2.95

1.1

1.0

283.50

286.50

mg/l

0.06

134

Other diseases of blood and blood-forming organs

198

1.83

2.93

1.0

306.63

285.38

mg/l

0.88

177

Disorders of eyelid, lacrimal system and orbit

367

2322

1.20

2.90

1.1

293.51

419.67

mg/l

0.49

329

2082

Oter anti-inflammatory and antirheumatic agents, non-steroids

288

1.52

2.90

1.1

1.0

285.77

302.48

mg/l

1.16

259

Fall on same level involving ice and snow

243

1949

1.25

2.89

1.1

296.72

288.93

mg/l

0.69

217

1741

Vasomotor and allergic rhinitis

169

1272

1.31

2.88

1.1

295.95

290.68

mg/l

0.43

148

1165

Phlebitis and thrombophlebitis (not including DVT)

617

1.45

2.85

1.1

1.0

297.95

289.60

mg/l

0.53

556

Disorders of vestibular function (Vertigo)

179

1363

1.29

2.85

1.1

1.0

291.42

293.40

mg/l

0.14

156

1211

Myocardial infarction, without ST-elevation

130

875

1.36

2.84

1.0

301.24

286.44

mg/l

1.30

117

778

Other degenerative diseases of the nervous system

476

1.45

2.83

1.0

273.35

295.95

mg/l

2.50

425

Monoamine oxidase A inhibitors

291

1.66

2.80

1.2

1.0

287.95

287.77

mg/l

0.01

266

Decubitus ulcer and pressure area

137

1.98

2.80

1.0

299.23

281.07

mg/l

0.51

119

Other embolism and thrombosis

322

1.62

2.80

1.1

1.0

301.66

290.86

mg/l

0.47

290

Allergic asthma (mode)

102

712

1.41

2.79

1.0

1.1

292.13

285.73

mg/l

0.41

648

Soft tissue disorders related to use, overuse and pressure

107

770

1.39

2.79

1.1

290.05

288.42

mg/l

0.09

688

Dermatopolymyositis

3.62

2.79

1.0

1.1

304.00

284.48

mg/l

—

Polyarthrosis

491

1.48

2.78

1.0

1.1

285.39

295.36

mg/l

0.55

432

Other disorders of carbohydrate metabolism

8.53

2.76

1.0

1.2

241.40

261.00

mg/l

—

Hypermobility syndrome

131

2.00

2.75

1.1

261.19

303.30

mg/l

2.41

118

Degeneration of macula and posterior pole

154

932

1.32

2.73

1.1

1.0

290.45

292.42

mg/l

0.12

139

812

Venous thromboembolism

203

1551

1.27

2.73

1.1

1.0

303.46

289.11

mg/l

1.99

179

1384

Open wound of lower leg

419

1.53

2.73

1.0

1.1

291.47

286.46

mg/l

0.22

378

Paracetamol or NSAID medication

270

1.50

2.72

1.0

1.1

288.31

281.72

mg/l

0.23

248

Pericarditis

2.16

2.71

1.0

305.52

274.46

mg/l

1.06

COPD, hospital admissions 1, only main diagnosis

110

683

1.38

2.69

1.0

308.94

284.21

mg/l

2.85

610

Status post-ami

454

1.45

2.68

1.0

296.27

281.34

mg/l

0.94

396

Tic and related disorders

3.80

2.68

1.1

256.11

286.89

mg/l

—

Periapical abscess

201

1596

1.26

2.65

1.1

287.49

288.13

mg/l

0.04

180

1431

Disorders of sclera, cornea, iris and ciliary body

233

1884

1.24

2.62

1.1

290.66

287.94

mg/l

0.25

211

1690

Acute suppurative otitis media

129

902

1.34

2.61

1.1

293.12

282.72

mg/l

0.60

119

827

Suppurative and unspecified otitis media

168

1158

1.29

2.59

1.1

290.75

285.50

mg/l

0.31

157

1053

Pulmonary heart disease, diseases of pulmonary circulation

113

833

1.36

2.57

1.1

1.0

314.87

287.11

mg/l

3.24

104

745

Pre-eclampsia or eclampsia

665

1.40

2.56

1.1

291.86

304.49

mg/l

0.92

585

Superficial injury of wrist and hand

699

1.39

2.55

1.1

299.87

282.90

mg/l

1.43

640

Familial hypercholesterolemia, with ischemic heart disease

178

1.80

2.55

1.0

296.96

290.24

mg/l

0.18

153

Stroke, excluding SAH

220

1289

1.25

2.55

1.1

288.18

289.91

mg/l

0.13

194

1149

Spondylosis

212

1384

1.25

2.54

1.1

283.16

505.45

mg/l

0.53

187

1248

Superficial injury of hip and thigh

370

1.54

2.54

1.1

1.0

281.63

289.59

mg/l

0.34

329

Rheumatoid arthritis

126

848

1.33

2.53

1.0

293.11

645.53

mg/l

0.50

112

752

Triptan medication for migraine, min. 3 purchases

266

1666

1.22

2.52

1.1

291.37

296.45

mg/l

0.56

246

1498

Arthrosis

308

1401

1.21

2.51

1.0

1.1

280.83

501.16

mg/l

0.53

269

1258

Angina pectoris

214

1142

1.25

2.50

1.1

286.61

284.73

mg/l

0.13

194

1013

Other disorders of veins

155

1195

1.29

2.49

1.0

1.1

303.00

543.38

mg/l

0.48

129

1069

COPD, early/later onset

155

1011

1.29

2.48

1.0

1.1

303.63

286.59

mg/l

2.02

135

895

Lichen planus

357

1.55

2.47

1.0

288.92

292.51

mg/l

0.14

320

Other viral diseases, not elsewhere classified

125

938

1.33

2.46

1.1

294.01

285.86

mg/l

0.37

120

855

Necrosis of pulp, including avohilmo

265

2182

1.21

2.46

1.1

292.79

288.22

mg/l

0.46

232

1977

Myocardial infarction

181

1003

1.27

2.46

1.0

1.1

295.09

283.22

mg/l

1.23

166

893

COPD, hospital admission 2, with asthma infections

102

640

1.37

2.41

1.0

1.1

310.78

284.84

mg/l

2.68

573

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

250

1.65

2.39

1.1

1.0

293.18

290.88

mg/l

0.06

223

COPD, hospital admissions

153

1005

1.29

2.39

1.0

1.1

303.43

286.68

mg/l

1.94

134

888

Disorders of phosphorus metabolism and phosphatases

6.39

2.38

1.0

1.1

271.00

303.25

mg/l

—

Tonsillectomy and adenotomy

278

1604

1.21

2.38

1.1

290.25

288.92

mg/l

0.11

254

1452

Medical abortion

254

1128

1.22

2.36

1.1

306.65

302.16

mg/l

0.40

223

998

Stroke, including SAH

236

1398

1.23

2.36

1.1

287.71

290.66

mg/l

0.26

210

1245

Fracture of skull and facial bones

701

1.37

2.36

1.1

1.0

274.93

282.23

mg/l

0.47

632

Diseases of inner ear

207

1619

1.24

2.35

1.1

292.22

291.30

mg/l

0.07

180

1445

Pollen allergy

668

1.38

2.33

1.1

290.26

287.43

mg/l

0.14

616

Persons encountering health services in circumstances related to reproduction

282

1580

1.20

2.32

1.1

289.26

474.61

mg/l

0.49

254

1424

Benign neoplasm: Pancreas

2.33

2.32

1.0

283.27

293.80

mg/l

0.19

Tic disorders

3.25

2.31

1.1

1.0

256.11

301.52

mg/l

—

Haemorrhoids and perianal venous thrombosis

107

796

1.34

2.30

1.1

280.09

288.67

mg/l

0.82

718

Other neurological diseases

281

1842

1.20

2.30

1.1

282.84

291.50

mg/l

1.32

252

1642

Dermatopolymyositis (FG)

2.98

2.29

1.0

1.1

304.00

294.86

mg/l

—

Diseases of appendix

335

2563

1.18

2.29

1.1

291.54

404.69

mg/l

0.49

304

2305

Diabetes mellitus in pregnancy

140

690

1.30

2.27

1.0

1.1

314.58

305.51

mg/l

0.66

128

632

COPD-related respiratory insufficiency

254

1.62

2.26

1.0

298.88

285.30

mg/l

0.67

224

Solid cancers, helper endpoint

375

1891

1.17

2.25

1.1

296.69

444.33

mg/l

0.46

332

1700

severe traumatic brain injury, does not include concussion

555

1.41

2.24

1.1

1.0

269.74

282.18

mg/l

0.87

500

Drug-induced osteoporosis with pathological fracture

3.14

2.23

1.0

321.22

297.33

mg/l

—

Insulin, fast-acting (human)

448

1.46

2.23

1.2

1.1

332.34

281.45

mg/l

3.65

410

Non-allergic asthma (mode), excluding more controls

479

1.43

2.17

1.0

1.1

314.81

284.61

mg/l

1.23

427

Burns and corrosions of external body surface, specified by site

345

1.51

2.16

1.0

1.1

290.02

281.81

mg/l

0.32

315

Contact with machinery

329

1.53

2.16

1.1

276.40

278.48

mg/l

0.09

302

Burns and corrosions

452

1.44

2.14

1.0

1.1

284.44

282.79

mg/l

0.06

412

Use of memantine

364

0.57

2.14

1.0

288.00

293.90

mg/l

0.16

317

Use of other anti-dementia drugs

364

0.57

2.14

1.0

288.00

293.90

mg/l

0.16

317

Malignant neoplasm

379

1926

1.17

2.14

1.1

297.87

441.03

mg/l

0.45

337

1733

Localized swelling, mass and lump of skin and subcutaneous tissue

127

983

1.29

2.13

1.1

1.0

293.40

290.31

mg/l

0.18

118

878

Redundant prepuce, phimosis and paraphimosis

100

741

1.34

2.13

1.2

1.1

267.48

271.79

mg/l

0.31

683

Haemorrhage in early pregnancy

113

838

1.31

2.13

1.1

299.62

303.68

mg/l

0.24

101

744

Endometriosis of ovary

458

1.43

2.11

1.0

1.1

301.46

303.70

mg/l

0.10

409

Open wound of forearm

275

1.57

2.11

1.1

293.92

285.58

mg/l

0.31

246

Triptan medication for migraine, single purchase ok

366

2130

1.16

2.10

1.1

285.24

430.57

mg/l

0.53

333

1919

Migraine, single triptan purchase ok & required. ICD-code if available is included

366

2130

1.16

2.10

1.1

285.24

430.57

mg/l

0.53

333

1919

Kyphosis

3.23

2.10

1.0

1.1

291.25

287.05

mg/l

—

Cervicobrachial syndrome

674

1.35

2.09

1.1

277.52

291.58

mg/l

1.41

600

Cardiomyopathy in other diseases

5.10

2.08

1.0

267.80

319.50

mg/l

—

Other otitis externa (chronic)

183

1.70

2.08

1.1

1.0

316.56

290.88

mg/l

1.13

165

Benign neoplasm: other/unspecified salivary gland

0.00

2.07

0.0

1.1

—

295.13

—

Car occupant injured in other and unspecified transport accidents

633

1.36

2.06

1.1

280.23

286.82

mg/l

0.38

576

Viral and other specified intestinal infections

686

1.34

2.03

1.2

1.1

298.34

283.07

mg/l

0.94

620

Other obstetric conditions, not elsewhere classified

135

670

1.28

2.02

1.0

1.1

303.69

307.01

mg/l

0.17

129

607

Diseases of male genital organs

243

1017

1.21

2.02

1.1

269.60

273.84

mg/l

0.43

221

932

Appendicitis, broad definition

329

2553

1.17

2.02

1.1

292.07

405.12

mg/l

0.48

299

2296

Contraceptive management

202

1160

1.22

2.02

1.1

295.63

545.95

mg/l

0.49

185

1050

Pain in thoracic spine

433

1.44

2.01

1.0

1.1

269.54

288.71

mg/l

1.71

392

Other inflammation of eyelid

400

1.45

2.01

1.1

1.0

291.19

291.98

mg/l

0.03

358

Supplementary factors related to causes of morbidity and mortality classified elsewhere

131

1027

1.28

2.01

1.1

291.92

285.45

mg/l

0.37

120

928

Oral lichen planus and hypothyroidism or thyroxine medication

2.66

2.01

1.0

1.1

291.70

287.19

mg/l

—

Tic and related disorders

2.84

2.01

1.1

1.0

256.11

302.00

mg/l

—

Unstable angina pectoris

118

720

1.29

1.96

1.1

290.30

283.61

mg/l

0.42

108

631

Non-allergic asthma (mode)

490

1.40

1.94

1.0

1.1

314.81

285.16

mg/l

1.20

438

Viral pneumonia

354

1.47

1.94

1.1

314.60

287.30

mg/l

0.72

319

Pre-eclampsia

623

1.35

1.94

1.1

294.60

304.65

mg/l

0.62

549

Allergic urticaria

234

1.59

1.92

1.1

1.0

295.50

294.00

mg/l

0.04

211

Disorders of vitreous body

186

1474

1.22

1.92

1.1

300.60

494.61

mg/l

0.47

155

1315

Other maltreatment syndromes

106

1.90

1.91

1.1

289.70

278.95

mg/l

0.23

Injuries to the neck

754

1.32

1.91

1.0

286.83

286.89

mg/l

0.00

684

Unspecific neurodegenerative disorder

586

0.71

1.89

1.0

292.60

291.39

mg/l

0.04

508

Diabetic retinopathy, strict definition

620

1.33

1.89

1.0

1.1

311.14

283.70

mg/l

2.35

552

Viral infections characterized by skin and mucous membrane lesions

372

2771

1.15

1.86

1.1

292.27

397.46

mg/l

0.49

345

2484

Complications predominantly related to the puerperium

105

811

1.30

1.84

1.0

1.1

299.76

302.87

mg/l

0.17

715

Viral infections characterized by skin and mucous membrane lesions

173

1417

1.22

1.83

1.1

296.03

286.72

mg/l

0.59

162

1268

Mouth breathing

168

1372

1.22

1.82

1.0

1.1

294.45

283.04

mg/l

1.17

152

1238

Superficial injury of shoulder and upper arm

327

1.47

1.81

1.0

296.41

284.46

mg/l

0.48

298

Deforming dorsopathies

108

840

1.29

1.80

1.1

302.60

291.94

mg/l

0.49

751

Motor disorders, excluding more controls

2.60

1.80

1.0

1.2

262.89

271.21

mg/l

—

Tobacco use

161

1.69

1.78

1.1

1.0

273.32

284.11

mg/l

0.31

148

Calculus of kidney and ureter

110

860

1.28

1.77

1.1

273.64

282.81

mg/l

0.76

778

Dentofacial anomalies [including malocclusion]

318

2210

1.16

1.77

1.0

1.1

285.20

425.32

mg/l

0.53

281

1993

116

836

1.27

1.77

1.0

301.47

292.52

mg/l

0.71

100

733

Abscess of anal and rectal regions

240

1.55

1.75

1.1

310.38

285.73

mg/l

0.42

219

Diabetic retinopathy

173

883

1.22

1.75

1.0

1.1

299.01

284.89

mg/l

1.54

154

777

Complications of internal orthopaedic prosthetic devices, implants and grafts

548

1.35

1.75

1.0

295.98

290.94

mg/l

0.24

491

Asthma/COPD (KELA code 203)

415

2507

1.14

1.74

1.1

293.60

406.18

mg/l

0.47

367

2256

Rheumatoid arthritis, including avohilmo

143

1156

1.24

1.74

1.0

1.1

292.39

294.24

mg/l

0.11

128

1027

Myocardial infarction, strict

158

915

1.23

1.74

1.0

1.1

300.63

282.23

mg/l

2.13

143

815

Lesion of lateral popliteal nerve

132

1.75

1.74

1.2

1.1

291.17

286.45

mg/l

0.11

119

Disorders of vitreous body and globe

189

1510

1.20

1.73

1.1

301.61

489.72

mg/l

0.47

157

1345

Other bullous disorders

2.07

1.70

1.0

273.21

286.02

mg/l

0.21

All influenza (not pneumonia)

457

1.38

1.70

1.3

1.1

287.93

284.48

mg/l

0.13

413

Etanercept

211

1.57

1.68

1.1

1.0

276.04

292.42

mg/l

0.70

190

Need for other prophylactic measures

172

1.64

1.67

1.1

1.0

323.75

278.46

mg/l

1.00

153

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

166

1364

1.21

1.67

1.1

290.53

287.23

mg/l

0.23

154

1235

Viral warts

728

1.29

1.65

1.1

304.14

285.16

mg/l

0.76

663

Retinal detachments and breaks

119

949

1.26

1.65

1.1

291.85

287.66

mg/l

0.26

109

843

Hypoparathyroidism

1.98

1.64

1.0

321.67

290.03

mg/l

1.07

Cardiodefibrillation

114

903

1.26

1.64

1.0

2808.79

285.04

mg/l

0.50

106

806

Ischaemic Stroke, excluding all haemorrhages

194

1208

1.20

1.63

1.1

1.0

285.26

291.22

mg/l

0.57

172

1076

Dermatographic urticaria

189

1.59

1.63

1.1

1.0

278.87

296.58

mg/l

0.73

170

Need for immunization against other single viral diseases

2.16

1.62

1.2

1.0

307.17

281.45

mg/l

0.43

Pregnancy with abortive outcome

255

1136

1.17

1.61

1.1

302.94

302.17

mg/l

0.05

223

1006

Sequelae of cerebrovascular disease

109

743

1.27

1.61

1.0

290.26

289.08

mg/l

0.06

663

Crystal arthropathies, rheuma endpoint

2.52

1.60

1.0

1.1

294.75

302.78

mg/l

—

Assault by blunt object

2.35

1.59

1.3

1.0

254.70

283.53

mg/l

—

Ethmoidectomy

404

1.39

1.59

1.2

1.0

275.56

287.93

mg/l

0.68

367

Primary_lymphoid and hematopoietic malignant neoplasms

619

1.31

1.58

1.1

1.0

312.96

286.85

mg/l

1.90

550

Benign neoplasm: Pituitary gland, craniopharyngeal duct

144

1.67

1.57

1.1

1.0

306.96

289.73

mg/l

0.48

128

Fitting and adjustment of other devices

112

805

1.26

1.57

1.0

285.00

290.28

mg/l

0.38

105

720

Other benign neoplasms of skin

134

1091

1.23

1.56

1.1

294.57

291.05

mg/l

0.15

113

975

Contact with and exposure to communicable diseases

1167

0.78

1.56

1.1

287.13

289.66

mg/l

0.12

1069

Peritonsillar abscess

682

1.29

1.56

1.1

292.76

285.54

mg/l

0.37

629

Thyrotoxicosis with toxic multinodular goitre

137

1.69

1.55

1.0

298.26

292.84

mg/l

0.15

116

Vestibular neuronitis

241

1.50

1.52

1.1

1.0

284.53

290.05

mg/l

0.21

218

Bullous disorders

138

1.67

1.51

1.0

289.17

289.98

mg/l

0.02

122

Nonsuppurative otitis media

100

683

1.27

1.51

1.1

295.11

284.88

mg/l

0.60

621

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

127

652

1.24

1.50

1.0

1.1

302.41

307.10

mg/l

0.24

121

589

Appendectomy

282

2351

1.15

1.50

1.0

1.1

292.87

415.59

mg/l

0.48

251

2118

Pain associated with micturition

308

1.43

1.49

1.0

277.06

295.04

mg/l

0.96

277

LSIL lesion of the vagina

2.39

1.46

1.0

1.1

312.67

289.97

mg/l

—

Pregnancy hypertension

165

1237

1.20

1.46

1.1

293.95

304.27

mg/l

0.98

153

1096

Pre-eclampsia or poor fetal growth

119

962

1.23

1.46

1.1

291.14

305.09

mg/l

1.32

109

852

Other superficial mycoses

318

1.42

1.45

1.0

1.1

302.74

284.50

mg/l

0.65

288

Embolic stroke

1.84

1.45

1.0

321.25

291.60

mg/l

0.93

Other and unspecified tonsillitis

153

1069

1.20

1.45

1.1

290.45

282.90

mg/l

0.40

136

977

Other abortion

3.16

1.44

1.0

1.1

278.40

274.38

mg/l

—

Superficial injury of abdomen, lower back and pelvis

429

1.35

1.44

1.1

283.85

285.06

mg/l

0.04

389

Eustachian salpingitis and obstruction

261

1.46

1.43

1.1

278.21

276.67

mg/l

0.05

239

Excessive attrition of teeth

241

2088

1.16

1.43

1.0

1.1

287.54

290.47

mg/l

0.27

210

1891

Status epilepticus

1.86

1.40

1.1

1.0

285.20

285.86

mg/l

0.01

Disorders of conjunctiva

358

2555

1.13

1.40

1.1

293.90

406.26

mg/l

0.48

320

2297

Oxicams

335

1.31

1.40

1.1

1.0

276.18

297.09

mg/l

1.65

300

Organic, including symptomatic, mental disorders

154

915

1.20

1.37

1.1

1.0

293.36

291.48

mg/l

0.11

135

809

Other disorders of the musculoskeletal system and connective tissue

416

1.35

1.37

1.1

1.0

295.51

289.45

mg/l

0.22

378

Other chronic obstructive pulmonary disease, including avohilmo

183

1285

1.18

1.37

1.0

1.1

1950.73

285.97

mg/l

0.50

161

1148

Endometriosis ASRM stages 3,4

670

1.27

1.36

1.0

1.1

297.50

299.88

mg/l

0.13

598

Speech therapy

768

1.25

1.36

1.1

303.45

288.68

mg/l

1.25

691

Benign paroxysmal vertigo

795

1.25

1.35

1.0

1.1

297.85

291.49

mg/l

0.43

713

Delivery

102

669

0.80

1.35

1.1

289.21

314.03

mg/l

3.82

581

Sequelae of injuries, of poisoning and of other consequences of external causes

778

1.25

1.34

1.1

1.0

295.82

283.00

mg/l

1.09

705

Hypoglycaemia, other or unspecified

191

1.52

1.34

1.1

1.0

308.24

287.09

mg/l

0.68

172

Stomatitis and related lesions

601

1.28

1.33

1.1

1.0

280.64

288.80

mg/l

0.44

539

Trochanteric bursitis

341

1.38

1.33

1.1

307.78

293.37

mg/l

0.88

308

Actinic keratosis

737

1.24

1.33

1.0

301.79

293.64

mg/l

0.55

641

Viral and other specified intestinal infections

118

934

1.22

1.32

1.2

1.1

305.29

281.73

mg/l

1.72

106

848

Pregnancy examination and test

311

1.32

1.1

305.05

321.43

mg/l

0.83

278

Leiomyoma of uterus

240

1180

1.15

1.32

1.1

298.09

560.06

mg/l

0.52

215

1040

Urolithiasis

112

916

1.22

1.30

1.1

273.41

282.17

mg/l

0.73

828

Focal epilepsy, strict definition

559

1.29

1.30

1.1

1.0

282.35

284.40

mg/l

0.07

503

Benign neoplasm of mouth and pharynx

309

1.40

1.29

1.0

1.1

294.24

288.02

mg/l

0.22

281

Bronchitis, not specified as acute or chronic

242

1.45

1.29

1.1

287.86

284.38

mg/l

0.13

221

Other disorders of breast

343

1.37

1.29

1.0

309.11

298.48

mg/l

0.40

303

All dysplastic lesions of the vagina

1.95

1.28

1.0

1.1

300.83

296.02

mg/l

0.12

Other bursopathies

327

1.38

1.27

1.0

308.37

283.41

mg/l

1.54

295

Endometriosis of pelvic peritoneum

451

1.31

1.27

1.1

309.51

305.96

mg/l

0.14

404

Primary open-angle glaucoma

690

0.76

1.26

1.0

296.37

291.27

mg/l

0.22

612

Effects of foreign body entering through natural orifice

102

830

1.23

1.26

1.0

1.1

274.95

279.95

mg/l

0.31

752

Open wound of wrist and hand

191

1608

1.16

1.26

1.1

284.28

281.88

mg/l

0.17

169

1466

Delivery, wide proxy

531

0.79

1.25

1.1

295.27

315.65

mg/l

1.65

462

Coronary artery bypass grafting

437

1.28

1.25

1.0

301.94

281.85

mg/l

1.19

379

Other disorders of central nervous system

2.42

1.24

1.0

272.17

280.25

mg/l

—

Keratitis

140

1177

1.19

1.24

1.1

292.75

286.35

mg/l

0.49

128

1055

Acute appendicitis

299

2485

1.13

1.23

1.1

290.72

408.02

mg/l

0.49

270

2237

Gestational diabetes (for exclusion)

147

861

1.19

1.23

1.0

1.1

301.52

304.56

mg/l

0.21

132

780

Acquired haemolytic anaemia

2.05

1.22

1.1

1.0

310.80

289.91

mg/l

—

Pulmonary embolism

772

1.23

1.20

1.1

1.0

313.92

287.51

mg/l

2.62

691

Malignant neoplasm of breast

120

940

0.83

1.20

1.1

312.93

615.68

mg/l

0.47

103

843

Pulmonary heart disease

773

1.23

1.18

1.1

1.0

313.92

287.10

mg/l

2.69

691

Other crystal arthropathies

2.12

1.18

1.0

1.1

294.75

299.76

mg/l

—

Skin changes due to chronic exposure to nonionizing radiation

102

771

1.22

1.18

1.0

302.20

292.95

mg/l

0.67

674

FESS (DNB20)

393

1.33

1.17

1.2

1.1

272.75

288.08

mg/l

0.86

357

Follicular cysts of skin and subcutaneous tissue

551

1.27

1.17

1.1

293.71

281.81

mg/l

0.69

495

Deep endometriosis

231

1.43

1.17

1.1

1.0

295.29

293.76

mg/l

0.04

203

Use of glatiramer acetate

2.02

1.17

1.2

1.1

259.60

290.60

mg/l

—

Carrier of infectious disease

2.01

1.16

1.0

1.1

295.70

292.64

mg/l

—

Seropositive rheumatoid arthritis

683

1.24

1.16

1.0

1.1

296.04

293.31

mg/l

0.12

614

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.00

1.15

0.0

1.0

—

290.80

—

Undescended testicle

0.00

1.14

0.0

1.1

—

296.55

—

Excessive earwax

201

1711

1.15

1.14

1.0

1.1

288.87

288.26

mg/l

0.04

179

1527

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.00

1.13

0.0

1.0

—

290.28

—

Other abnormal findings of blood chemistry

103

1.66

1.13

1.1

1.0

283.82

289.27

mg/l

0.12

Artrosis, including avohilmo

365

1801

1.11

1.12

1.0

1.1

280.62

291.06

mg/l

1.76

320

1639

Unspecified acute lower respiratory infection

458

1.29

1.11

1.1

1.0

299.65

279.59

mg/l

1.15

419

Achilles tendinitis

311

1.35

1.09

1.1

1.0

284.09

285.77

mg/l

0.06

287

Operations for atrial fibrillation

1.97

1.09

1.0

320.12

292.72

mg/l

—

Allergic colitis

1.96

1.08

1.0

1.1

246.75

291.75

mg/l

—

Raynaud syndrome

269

1.38

1.08

1.0

292.16

291.66

mg/l

0.01

243

Type of accident

113

947

1.19

1.08

1.1

1.0

288.47

286.00

mg/l

0.11

103

857

Allergic purpura

1.76

1.07

1.1

1.0

308.15

293.58

mg/l

0.24

Use of anticholinesterases

495

0.76

1.07

1.0

295.13

291.75

mg/l

0.10

429

N06DA Anticholinesterases

495

0.76

1.07

1.0

295.12

291.75

mg/l

0.10

429

Polyarthritis, unspecified

1.66

1.07

1.2

1.0

271.56

293.30

mg/l

0.52

Conjunctivitis

323

2433

1.11

1.06

1.1

295.36

413.23

mg/l

0.48

292

2186

Meniscus derangement

217

1286

1.14

1.06

1.0

1.1

287.87

519.03

mg/l

0.50

194

1154

Malignant neoplasm of breast, ER-positive, including Hilmo

809

0.82

1.06

1.1

1.0

318.07

666.98

mg/l

0.46

723

Salpingitis and oophoritis

515

1.26

1.06

1.0

1.1

290.61

298.63

mg/l

0.46

452

Hypertrophy of breast

552

1.25

1.04

1.2

1.0

290.57

302.33

mg/l

0.90

488

Allergic rhinitis

136

1151

1.17

1.02

1.1

292.43

289.72

mg/l

0.17

120

1049

Carcinoma in situ of breast, intraductal

215

0.60

1.02

1.0

324.29

297.53

mg/l

—

186

Impacted cerumen

255

1.38

1.02

1.0

285.39

290.53

mg/l

0.14

224

Gonarthrosis, primary, with knee surgery

152

1399

0.86

1.02

1.1

280.63

504.87

mg/l

0.53

125

1250

Benign leiomyoma with endometriosis

403

1.29

1.01

1.1

1.0

297.65

300.59

mg/l

0.12

355

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

624

0.77

1.01

1.1

1.0

309.33

287.70

mg/l

1.18

563

Dislocation, sprain and strain of joints and ligaments at neck level

483

1.27

1.01

1.0

288.71

288.22

mg/l

0.01

436

Gonarthrosis

249

1262

1.12

1.01

1.0

1.1

281.91

524.95

mg/l

0.52

210

1132

Postmenopausal atrophic vaginitis

418

1.22

0.99

1.1

307.89

1022.30

mg/l

0.50

371

Focal epilepsy

610

1.23

0.98

1.1

1.0

283.54

283.83

mg/l

0.01

547

Infection due to other mycobacteria

2.18

0.98

1.0

326.80

259.00

mg/l

—

Covid-19 suspected case

756

1.21

0.98

1.0

1.1

300.96

288.18

mg/l

0.83

693

Other and unspecified epidermal thickening

1.86

0.96

1.0

1.1

304.60

285.15

mg/l

—

Oesophageal obstruction

1.75

0.96

1.0

277.50

298.74

mg/l

0.55

Malignant neoplasm of breast, HER2-negative

121

927

0.85

0.96

1.1

312.93

620.74

mg/l

0.47

103

830

Single spontaneous delivery

106

666

0.84

0.95

1.0

1.1

289.16

313.98

mg/l

3.97

578

COPD, hospital admissions 3, with asthma pneumonia sepsis

507

1.23

0.95

1.0

312.27

282.66

mg/l

2.39

456

Sequelae of external causes of morbidity and mortality

722

1.21

0.95

1.0

301.22

287.98

mg/l

0.85

645

Other peripheral vascular diseases

216

1.39

0.95

1.1

1.0

311.56

294.27

mg/l

0.52

197

Acute laryngitis and tracheitis

419

1.27

0.93

1.1

278.90

278.73

mg/l

0.01

383

Hypertrophy of breast in women and men

660

1.21

0.93

1.2

1.0

289.48

298.94

mg/l

0.74

589

Papillary adenocarcinoma of thyroid gland

143

0.56

0.93

1.1

1.0

299.25

291.37

mg/l

—

126

Injury of muscle and tendon at shoulder and upper arm level

125

1075

1.16

0.92

1.0

290.88

282.30

mg/l

0.61

107

981

Nasal polyp

553

1.23

0.91

1.0

1.1

292.74

282.25

mg/l

0.61

502

Spondylolisthesis/Spondylolysis

508

1.24

0.91

1.1

291.30

289.51

mg/l

0.07

454

Obstructed labour due to malposition and malpresentation of fetus

723

0.81

0.90

1.1

294.33

307.16

mg/l

1.12

656

Long labour

692

0.82

0.90

1.0

1.1

306.02

306.85

mg/l

0.03

619

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

176

1351

1.13

0.89

1.1

293.28

526.78

mg/l

0.53

163

1194

Puerperal sepsis

350

1.29

0.88

1.0

1.1

283.30

300.40

mg/l

1.04

305

Malignant neoplasm of breast, HER-positive

799

0.84

0.88

1.1

1.0

318.07

672.09

mg/l

0.47

713

Panhypopituitarism

1.87

0.87

1.0

323.50

285.26

mg/l

—

Later onset COPD, excluding more controls

290

1.28

0.87

1.1

300.95

281.90

mg/l

0.92

250

Complications of the puerperium, not elsewhere classified

103

1.56

0.87

1.1

1.0

293.88

304.74

mg/l

0.26

Aortic aneurysm

502

1.23

0.86

1.0

287.83

279.85

mg/l

0.35

459

Male infertility

180

0.61

0.86

1.0

1.1

264.64

268.19

mg/l

0.07

168

Multiple delivery

252

0.67

0.86

1.1

285.82

315.02

mg/l

1.06

215

Hyperkinetic disorders (excl. ADHD)

1.78

0.85

1.0

1.1

297.60

290.96

mg/l

—

Benign neoplasm: Tongue

1.67

0.85

1.1

1.0

288.67

299.11

mg/l

0.21

Postpartum haemorrhage due to anatomy

282

1.31

0.84

1.1

290.03

297.64

mg/l

0.28

264

Sequelae with surgical and medical care as external cause

559

1.22

0.84

1.0

306.47

290.44

mg/l

0.85

502

Inguinal hernia

187

1404

0.89

0.84

1.1

273.77

279.78

mg/l

0.60

171

1276

Acute bronchiolitis

153

1.42

0.84

1.1

300.25

288.83

mg/l

0.31

139

Conductive and sensorineural hearing loss

301

1852

1.10

0.83

1.1

290.85

451.05

mg/l

0.50

269

1661

In situ neoplasms

120

1041

1.15

0.81

1.0

1.1

297.56

295.28

mg/l

0.12

108

927

Other menopausal disorders

470

0.83

0.81

1.0

1.1

294.98

942.58

mg/l

0.51

417

Focal epilepsy, mode (most common among epilepsy diagnosis)

535

1.22

0.80

1.1

1.0

284.72

283.45

mg/l

0.04

480

Hydrocele

320

1.28

0.80

1.1

273.09

274.42

mg/l

0.04

295

Glaucoma

144

1405

0.88

0.79

1.0

1.1

296.64

291.57

mg/l

0.40

129

1247

Acquired stenosis of external ear canal

0.00

0.79

0.0

1.0

—

288.11

—

Embolic stroke with flimmer

1.82

0.79

1.0

309.83

298.48

mg/l

—

Pathological resorption of teeth

1.54

0.78

1.1

1.0

248.00

288.59

mg/l

2.31

Malignant neoplasm of breast, including Hilmo

129

954

0.87

0.78

1.1

313.50

611.05

mg/l

0.47

110

856

Malignant neoplasm of breast, HER2-negative, including Hilmo

129

954

0.87

0.78

1.1

313.50

611.05

mg/l

0.47

110

856

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

208

1.35

0.77

1.1

1.0

291.04

301.21

mg/l

0.44

187

Iridocyclitis

704

1.18

0.76

1.1

295.25

284.99

mg/l

0.76

634

Outcome of delivery

337

1.21

0.76

1.0

1.1

306.25

317.01

mg/l

0.56

304

Bitten or struck by other mammals

359

1.26

0.75

1.0

1.1

282.42

293.51

mg/l

0.32

325

Medicines for HER+ breast cancer

1045

0.86

0.75

1.1

1.0

316.82

590.02

mg/l

0.46

918

Other and unspecified visual disturbances

297

1.28

0.75

1.0

281.52

293.45

mg/l

0.44

269

Pregnancy, childbirth and the puerperium

420

0.83

0.74

1.0

1.1

298.93

315.96

mg/l

0.93

366

Dementia in Alzheimer disease

225

0.71

0.73

1.0

268.67

295.32

mg/l

0.63

193

Acute nasopharyngitis (common cold)

421

1.23

0.73

1.0

281.47

275.06

mg/l

0.33

384

Oral leukoplakia, including avohilmo

1.59

0.72

1.0

294.00

289.42

mg/l

—

Single delivery by caesarean section

378

1.19

0.71

1.1

300.52

320.00

mg/l

1.14

337

Benign neoplasm: Skin of other and unspecified parts of face

264

1.29

0.71

1.1

1.0

269.52

289.18

mg/l

1.48

235

Erythema intertrigo

1.58

0.71

1.0

361.44

276.71

mg/l

—

Acute appendicitis, no complications

230

2088

1.10

0.71

1.1

294.87

287.85

mg/l

0.83

212

1879

Spondylopathies in diseases classified elsewhere

1.93

0.71

1.0

1.1

285.00

266.55

mg/l

—

Disorders of refraction and accommodation

931

0.86

0.70

1.0

1.1

280.31

289.00

mg/l

0.49

845

Gonarthrosis [arthrosis of knee](FG)

289

1544

1.09

0.70

1.0

1.1

285.18

482.22

mg/l

0.52

245

1388

Toxic effects of substances chiefly nonmedicinal as to source

354

1.25

0.70

1.1

284.72

283.82

mg/l

0.03

327

Unspecified nephritic syndrome

1.56

0.70

1.1

1.0

267.56

281.26

mg/l

—

Dislocation, sprain and strain of joints and ligaments of knee

252

2128

1.09

0.69

1.1

281.25

289.32

mg/l

1.04

226

1926

Allergic contact dermatitis due to drugs in contact with skin

1.67

0.68

1.1

1.0

293.29

300.35

mg/l

—

Coxarthrosis, primary, with hip surgery

113

1201

0.88

0.68

1.1

288.30

291.10

mg/l

0.19

1063

Retinal breaks without detachment

456

1.21

0.67

1.1

1.0

284.92

289.02

mg/l

0.19

406

Benign neoplasm: Vagina

1.79

0.66

1.0

1.1

288.00

287.83

mg/l

—

Chalazion

348

1.24

0.66

1.1

1.0

301.68

289.32

mg/l

0.53

318

Left ventricular outflow tract obstruction (LVOTO), broad definition

339

1.24

0.66

1.1

319.65

278.96

mg/l

1.83

312

Scissor bite

1.55

0.66

1.1

256.17

287.58

mg/l

1.03

Benign neoplasm: Skin of trunk

111

1.45

0.66

1.0

336.19

288.99

mg/l

0.43

Supervision of high-risk pregnancy

406

1.17

0.65

1.1

294.50

315.70

mg/l

1.81

370

Infectious mononucleosis

268

1.27

0.65

1.1

328.50

286.10

mg/l

1.14

246

Other/unspecified seropositive rheumatoid arthritis

735

1.16

0.65

1.0

1.1

296.04

293.17

mg/l

0.12

656

Injuries to the elbow and forearm

283

2300

1.08

0.65

1.0

1.1

296.31

417.66

mg/l

0.46

257

2065

Flat foot [pes planus] (acquired)

277

1.27

0.65

1.1

1.0

297.04

296.17

mg/l

0.02

245

Zoster [herpes zoster]

167

1484

1.11

0.65

1.1

1.0

298.06

290.56

mg/l

0.70

158

1308

Primary open-angle glaucoma, strict

579

0.83

0.64

1.0

296.98

292.49

mg/l

0.19

514

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

727

1.16

0.64

1.0

1.1

295.42

292.88

mg/l

0.11

650

Sensorineural hearing loss

275

1724

1.08

0.63

1.1

292.26

462.57

mg/l

0.49

245

1543

Mixed conductive and sensorineural hearing loss

305

1.25

0.63

1.1

1.0

281.41

290.55

mg/l

0.36

276

Nontraumatic intracranial haemmorrhage

441

1.20

0.63

1.0

295.91

287.23

mg/l

0.40

397

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.52

0.62

1.1

1.0

291.83

292.77

mg/l

0.02

Foreign body entering into or through eye or natural orifice

252

1.27

0.62

1.1

281.59

280.57

mg/l

0.03

228

Open wound of hip and thigh

101

0.59

0.62

1.2

1.0

239.00

275.11

mg/l

—

L02BG Aromatase inhibitors

846

0.86

0.62

1.1

1.0

305.19

301.44

mg/l

0.20

736

Unknown and unspecified causes of morbidity

173

1.33

0.61

1.0

298.91

286.77

mg/l

0.32

152

malignant neoplasm of female genital organs

355

0.78

0.61

1.1

1.0

305.48

300.39

mg/l

0.14

315

Intracerebral haemorrhage

262

1.26

0.60

1.0

306.64

286.84

mg/l

0.74

231

Other specific arthropathies, wide

1.57

0.60

1.0

331.50

293.52

mg/l

—

Seropositive rheumatoid arthritis, strict definition

434

0.81

0.60

1.0

297.67

291.04

mg/l

0.17

388

Malignant neoplasm of colon, including Hilmo

425

1.20

0.60

1.1

1.0

302.13

287.01

mg/l

0.71

382

Other disorders of bone density and structure

1.57

0.58

1.0

274.80

294.25

mg/l

—

Ulcer of vagina/vulva

1.51

0.58

1.0

283.25

311.75

mg/l

—

Seropositive rheumatoid arthritis, wide

743

1.14

0.58

1.0

1.1

296.04

293.40

mg/l

0.11

664

Other disorders of cornea

273

1.25

0.58

1.0

292.97

288.87

mg/l

0.17

247

Mental and behavioural disorders due to use of other stimulants, including caffeine

106

1.42

0.57

1.0

1.1

291.93

275.89

mg/l

0.65

Myasthenia gravis

1.67

0.57

1.0

319.50

292.26

mg/l

—

Malignant neoplasm of testis

1.46

0.56

1.1

1.0

241.37

263.45

mg/l

—

Labour and delivery complicated by fetal stress [distress]

530

0.86

0.56

1.1

289.59

308.57

mg/l

1.18

484

Dislocation, sprain and strain of joints and ligaments of thorax

0.56

1.0

262.40

289.83

mg/l

—

Female infertility

103

554

1.13

0.55

1.0

1.1

291.86

842.02

mg/l

0.51

495

Postpartum hemorraghe, parous women as controls

667

1.14

0.55

1.1

300.21

298.66

mg/l

0.07

612

Anterior Iridocyclitis

616

1.15

0.55

1.1

1.0

298.68

286.12

mg/l

0.91

552

Diabetic maculopathy

475

1.17

0.54

1.1

294.08

282.97

mg/l

0.62

420

Lateral epicondylitis

403

1.19

0.54

1.0

1.1

7099.23

285.33

mg/l

0.49

365

Malignant neoplasm of bladder, including Hilmo

220

1.27

0.54

1.0

283.65

280.84

mg/l

0.08

195

Melanocytic naevi

108

965

1.12

0.54

1.0

1.1

298.04

290.30

mg/l

0.51

100

868

Gestational [pregnancy-induced] hypertension

803

1.13

0.54

1.1

285.33

304.72

mg/l

1.65

707

Dermatophytosis

237

2198

1.08

0.53

1.1

288.79

287.25

mg/l

0.12

214

1988

Lichen simplex chronicus

1.43

0.53

1.0

286.62

282.71

mg/l

0.08

Acute and subacute iridocyclitis

581

1.15

0.53

1.1

1.0

301.53

284.99

mg/l

1.28

524

Endometriosis ASRM stages 1,2

544

1.16

0.52

1.1

311.13

299.12

mg/l

0.65

482

Embedded and impacted teeth

112

829

1.12

0.52

1.1

289.13

285.21

mg/l

0.18

104

758

Other noninflammatory disorders of uterus, except cervix

378

1.16

0.52

1.0

311.85

1103.32

mg/l

0.49

333

Burns and corrosions confined to eye and internal organs

1.45

0.52

1.1

249.14

279.86

mg/l

—

Disorders of puberty

1.50

0.51

1.0

1.1

257.00

304.00

mg/l

—

Conjunctivitis (acute, non atopic)

107

956

1.12

0.51

1.1

297.98

288.33

mg/l

0.42

100

865

Varicose veins

199

1387

1.08

0.51

1.0

1.1

304.06

509.64

mg/l

0.47

177

1240

Leisure time condition

546

1.15

0.50

1.1

1.0

274.89

285.36

mg/l

0.57

492

Seborrhoeic keratosis

565

1.15

0.50

1.1

1.0

287.49

288.54

mg/l

0.04

507

Short Achilles tendon (acquired)

1.50

0.49

1.1

296.90

291.15

mg/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

186

1297

1.08

0.49

1.0

1.1

306.66

533.79

mg/l

0.49

169

1156

Haemorrhagic and haematological disorders of fetus and newborn

1.56

0.49

1.0

1.1

317.29

276.79

mg/l

—

Degenerative diseases of the nervous system

492

0.87

0.48

1.0

271.90

290.64

mg/l

1.30

435

Premature rupture of membranes

513

1.13

0.47

1.1

291.74

310.60

mg/l

1.40

461

Macular pucker

327

1.19

0.47

1.1

1.0

308.38

289.06

mg/l

0.91

286

Superficial injury of forearm

300

1.20

0.46

1.1

1.0

274.32

287.21

mg/l

0.45

272

Presence of other functional implants

184

1183

1.08

0.44

1.1

1.0

294.77

290.88

mg/l

0.29

163

1038

Malignant melanoma

357

1.18

0.44

1.1

1.0

289.22

285.12

mg/l

0.13

323

Any dementia

535

0.88

0.44

1.0

285.43

292.59

mg/l

0.33

470

Other disorders of conjunctiva

385

1.17

0.44

1.0

283.41

291.29

mg/l

0.25

342

Hypertensive Renal Disease

1.37

0.44

1.0

313.71

280.82

mg/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

648

1.13

0.44

1.0

306.84

294.83

mg/l

0.75

579

Ectopic pregnancy

535

1.14

0.44

1.0

1.1

324.59

296.42

mg/l

1.58

473

Other disorders of bladder

284

1.20

0.43

1.0

277.93

286.01

mg/l

0.29

256

Ganglion

640

1.13

0.42

1.1

297.21

291.14

mg/l

0.27

582

Corneal ulcer

593

1.13

0.42

1.1

1.0

301.17

284.98

mg/l

0.87

539

Monoarthritis, not elsewhere classified

122

1.31

0.42

1.0

295.94

289.85

mg/l

0.14

110

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.57

0.42

1.2

1.0

266.40

288.42

mg/l

—

Cystic kidney disease

1.38

0.42

1.2

1.0

302.17

273.73

mg/l

0.51

Procedures for purposes other than remedying health state

1.41

0.42

1.1

297.00

295.33

mg/l

—

Pedal cyclist injured in transport accident

755

1.11

0.42

1.0

1.1

286.55

284.84

mg/l

0.09

688

Medial epicondylitis

1.36

0.41

1.0

1.1

294.77

282.50

mg/l

0.24

HSIL lesion of the vagina

1.52

0.41

1.0

1.1

274.20

296.75

mg/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

114

1042

1.09

0.41

1.1

290.57

283.94

mg/l

0.40

945

Granuloma annulare

1.52

0.41

3.4

1.0

279.20

298.89

mg/l

—

Liveborn infants according to place of birth

0.00

0.41

0.0

1.1

—

308.67

—

Brachial plexus disorders

286

1.19

0.41

1.1

1.0

8121.03

289.62

mg/l

0.49

261

Coxarthrosis

170

1042

1.08

0.41

1.1

287.36

575.49

mg/l

0.50

150

930

Polycythaemia vera

1.40

0.40

1.1

1.0

303.64

281.90

mg/l

0.55

Labour and delivery complicated by umbilical cord complications

132

1.29

0.40

1.0

285.47

301.58

mg/l

0.38

120

Acute appendicitis, with complications

615

1.12

0.40

1.1

1.0

275.57

282.85

mg/l

0.40

559

Malignant neoplasm of testis, including Hilmo

1.31

0.39

1.1

1.0

241.38

266.85

mg/l

—

Neonatal jaundice from other and unspecified causes

1.43

0.39

1.0

1.1

314.80

284.76

mg/l

—

Female infertility, cervical, vaginal, other or unspecified origin

548

1.10

0.39

1.0

1.1

291.83

848.93

mg/l

0.51

489

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

1.35

0.38

1.2

1.0

250.42

274.88

mg/l

0.46

Assault by unspecified means

1.39

0.37

1.0

297.60

279.58

mg/l

—

Dislocation, sprain and strain of joints and ligaments of head

125

1.28

0.37

1.1

257.25

292.24

mg/l

2.64

112

Suggestive for eosinophilic asthma

262

1.18

0.37

1.0

297.00

285.69

mg/l

0.35

238

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

220

1642

1.06

0.36

1.1

301.97

479.89

mg/l

0.49

198

1470

Disorders of breast

172

1461

1.07

0.36

1.1

302.49

509.67

mg/l

0.50

154

1293

Exposure to other and unspecified animate mechanical forces

1.36

0.36

1.0

261.64

295.92

mg/l

1.24

Benign neoplasm: Skin of eyelid, including canthus

412

1.14

0.36

1.0

303.03

290.62

mg/l

0.52

366

Anomalies of dental arch relationship, including avohilmo

636

1.11

0.36

1.0

1.1

294.01

290.25

mg/l

0.14

583

Benign neoplasm of eye and adnexa

272

1.18

0.36

1.0

316.74

291.47

mg/l

0.94

244

Benign neoplasm of ovary

450

1.13

0.36

1.0

1.1

290.33

300.14

mg/l

0.35

394

Other disorders involving the immune mechanism, not elsewhere classified

1.34

0.36

1.2

1.0

250.42

276.10

mg/l

0.49

Disorders in reading

1.43

0.35

1.0

1.1

272.17

292.14

mg/l

—

Respiratory conditions due to other external agents

1.43

0.35

1.0

377.00

292.23

mg/l

—

Aortic valve malfunction, age under 60 years

319

1.16

0.35

1.1

315.33

279.79

mg/l

1.40

295

Nontoxic goitre/thyroid nodule

832

1.09

0.35

1.1

1.0

293.33

297.52

mg/l

0.25

731

Epiphora

1.40

0.35

1.0

277.00

292.20

mg/l

—

Postpartum hemorraghe, all women as controls

800

1.10

0.35

1.1

300.21

303.87

mg/l

0.17

723

Other and unspecified vascular occlusions

190

1.21

0.34

1.0

306.83

286.84

mg/l

0.66

164

Other disorders of Eustachian tube

1.37

0.34

1.3

1.0

279.60

291.53

mg/l

—

Other and unspecified intracranial injuries

1.37

0.34

1.0

301.10

286.85

mg/l

—

Malignant neoplasm of prostate, including Hilmo

461

0.90

0.34

1.0

1.1

275.44

273.04

mg/l

0.11

420

Fracture at wrist and hand level

134

1245

1.07

0.34

1.1

288.65

280.44

mg/l

0.70

121

1135

Disorders of puberty, all

1.34

0.34

1.0

1.1

257.00

306.64

mg/l

—

Dementia, including avohilmo

697

0.92

0.33

1.0

293.37

292.99

mg/l

0.02

612

Other epidermal thickening

109

1.29

0.33

1.0

290.71

289.33

mg/l

0.02

Certain conditions originating in the perinatal period

243

1.17

0.33

1.0

1.1

295.63

293.54

mg/l

0.04

224

Other osteochondropathies

219

1.19

0.33

1.1

255.35

285.80

mg/l

1.87

203

Disorders of optic nerve, not elsewhere classified

1.28

0.32

1.0

325.00

295.70

mg/l

—

Chronic iridocyclitis

137

1.24

0.32

1.2

1.0

279.47

289.69

mg/l

0.37

121

Primary coxarthrosis, bilateral

686

0.90

0.32

1.1

1.0

291.13

291.96

mg/l

0.03

608

Female genital prolapse

488

1.09

0.31

1.0

1.1

290.65

917.74

mg/l

0.51

433

Carcinoma in situ of cervix uteri

273

0.84

0.31

1.1

1.0

318.43

300.56

mg/l

0.63

248

Strabismus

865

1.08

0.31

1.0

1.1

289.47

286.70

mg/l

0.14

778

Other fall from one level to another

743

1.09

0.30

1.0

1.1

282.75

283.11

mg/l

0.02

673

Other abnormal products of conception

121

746

1.07

0.30

1.1

310.88

302.08

mg/l

0.56

109

675

Multiple gestation

272

0.84

0.30

1.0

1.1

281.52

305.05

mg/l

1.29

245

Acute alcohol intoxication ICD-9

1.34

0.30

1.0

320.70

293.77

mg/l

—

Autonomic disorders

1.27

0.30

1.1

331.00

280.85

mg/l

—

Sudden idiopathic hearing loss

259

1.16

0.29

1.1

1.0

299.92

289.40

mg/l

0.29

234

Fracture of femur

527

1.10

0.29

1.1

1.0

303.19

287.36

mg/l

1.03

467

Herpesviral keratitis and keratoconjunctivitis

107

0.75

0.29

1.1

1.0

325.63

287.34

mg/l

—

Anogenital herpesviral [herpes simplex] infection

334

0.87

0.28

1.0

315.96

295.29

mg/l

0.23

305

Coxarthrosis [arthrosis of hip](FG)

183

1220

1.06

0.28

1.1

288.69

533.03

mg/l

0.50

161

1093

Pedal cyclist injured in other and unspecified transport accidents

345

1.13

0.28

1.1

295.06

288.14

mg/l

0.23

313

Fracture of forearm

186

1794

0.95

0.28

1.0

1.1

297.24

457.75

mg/l

0.47

172

1595

Bacterial pneumoniae

127

1050

1.07

0.28

1.1

296.93

285.29

mg/l

1.01

122

937

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

469

1.11

0.28

1.1

1.0

301.33

285.24

mg/l

0.88

421

Bursitis of shoulder

1.29

0.28

1.0

339.50

280.37

mg/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

153

951

0.94

0.27

1.0

1.1

301.61

307.34

mg/l

0.42

143

845

Primary gonarthrosis, bilateral

146

1324

0.94

0.27

1.1

285.12

516.53

mg/l

0.52

118

1183

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

139

0.79

0.27

1.1

1.0

278.36

296.33

mg/l

0.89

123

Lesion of ulnar nerve

414

1.11

0.26

1.1

1.0

292.66

283.19

mg/l

0.37

375

Ménière disease

234

1.15

0.26

1.1

1.0

289.96

291.99

mg/l

0.06

210

Hallux rigidus

376

1.12

0.26

1.1

285.74

293.52

mg/l

0.36

338

Mandibular retrognathia AND surgery (BSSO)

0.70

0.26

1.0

1.1

267.20

285.73

mg/l

—

Burn and corrosion of head and neck

0.68

0.26

1.0

359.60

284.16

mg/l

—

Dermatitis due to ingested food

100

1.25

0.26

1.0

1.1

262.31

288.99

mg/l

0.92

Glucosamine medication

121

1025

0.94

0.25

1.1

1.0

299.25

293.30

mg/l

0.48

102

901

Poor fetal growth

351

0.88

0.25

1.0

1.1

287.68

304.01

mg/l

0.74

319

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

215

2000

1.04

0.25

1.1

295.02

440.77

mg/l

0.49

191

1803

All dysplastic lesions of the cervix uteri

833

0.93

0.25

1.1

1.0

310.89

302.31

mg/l

0.55

745

Twin gestation

266

0.86

0.24

1.0

1.1

281.52

304.29

mg/l

1.24

239

Thoracic aortic aneurysm

359

1.11

0.24

1.1

1.0

272.16

279.91

mg/l

0.30

327

Other and unspecified disorders of vitreous body

130

1212

1.06

0.24

1.1

296.27

539.48

mg/l

0.49

109

1079

Hallux valgus (acquired)

113

764

1.06

0.24

1.1

308.29

686.64

mg/l

0.48

682

Spontaneous abortion

162

1038

1.05

0.24

1.1

2147.32

300.48

mg/l

0.50

145

922

Coxarthrosis, primary

169

1501

0.95

0.24

1.1

294.02

291.08

mg/l

0.19

148

1330

Polycystic ovarian syndrome, broad definition

312

1.12

0.24

1.1

300.10

306.65

mg/l

0.18

285

Other strabismus

723

1.08

0.23

1.0

1.1

294.03

288.24

mg/l

0.31

658

Prolapse and hernia of ovary and fallopian tube

1.34

0.23

1.0

338.00

293.40

mg/l

—

Other and unspecified glaucoma

147

0.82

0.23

1.0

300.67

291.46

mg/l

0.20

129

Adhesive middle ear disease

1.28

0.23

1.0

1.1

282.40

273.44

mg/l

—

Injuries to the hip and thigh

146

1257

1.05

0.23

1.1

297.09

287.53

mg/l

0.69

130

1119

Other aneurysm

134

1.20

0.23

1.0

300.38

285.34

mg/l

0.33

123

Schizotypal disorder

1.27

0.22

1.0

1.1

294.20

285.91

mg/l

—

Injury of muscle and tendon at ankle and foot level

1.27

0.22

1.0

265.60

286.04

mg/l

—

Keratoconus

1.27

0.22

1.0

297.40

285.51

mg/l

—

Antepartum haemorrhage, not elsewhere classified

238

1.14

0.22

1.1

305.64

306.95

mg/l

0.03

213

Other hearing loss

618

1.08

0.22

1.0

297.24

292.46

mg/l

0.23

559

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

528

1.08

0.21

1.1

301.13

285.05

mg/l

0.65

482

Malignant neoplasm of thymus, including Hilmo

0.00

0.21

0.0

1.1

—

285.50

—

Adrenogenital disorders

0.00

0.21

0.0

1.1

—

285.30

—

Other disorders of ear

357

2267

1.03

0.21

1.1

290.35

420.60

mg/l

0.50

320

2044

Atrial septal defect

104

0.76

0.21

1.0

1.1

350.38

290.92

mg/l

—

1.16

0.21

1.0

338.00

280.16

mg/l

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.20

0.0

1.0

—

311.86

—

Sexual dysfunction

1.23

0.20

1.0

293.33

291.77

mg/l

—

Dementia

628

0.94

0.19

1.0

292.85

293.28

mg/l

0.02

550

Maternal care for known or suspected abnormality of pelvic organs

578

1.06

0.19

1.1

307.52

310.10

mg/l

0.11

519

Other disorders of penis

308

1.10

0.19

1.0

1.1

271.42

276.59

mg/l

0.19

282

Other benign neoplasms of connective and other soft tissue

289

1.11

0.19

1.1

1.0

314.04

290.86

mg/l

0.63

261

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.13

0.18

1.0

1.1

259.83

275.27

mg/l

—

Postprocedural disorders of digestive system, not elsewhere classified

1.24

0.18

1.0

280.80

283.80

mg/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

138

905

1.05

0.18

1.1

1.0

301.92

287.25

mg/l

1.61

118

815

Pediculosis, acariasis and other infestations

560

1.07

0.18

1.1

292.53

285.85

mg/l

0.33

509

Allergic conjunctivitis

224

2111

1.03

0.18

1.1

294.10

433.24

mg/l

0.50

200

1902

Dysplasia of cervi uteri

525

1.06

0.17

1.1

310.43

872.11

mg/l

0.49

469

Other and unspecified corneal deformities and disorders

1.22

0.17

1.1

1.0

291.80

286.94

mg/l

—

Bacterial pneumonia (organism specified)

135

1174

1.04

0.17

1.1

299.97

286.96

mg/l

1.18

128

1047

Burns and corrosions of multiple and unspecified body regions

0.74

0.17

1.0

271.40

281.35

mg/l

—

Separation of retinal layers (serosa)

129

1.16

0.17

1.1

1.0

276.73

278.27

mg/l

0.03

116

Lymphoid leukaemia

129

1.16

0.17

1.0

296.30

286.42

mg/l

—

115

Injury of muscle and tendon at lower leg level

466

1.07

0.16

1.1

275.67

283.35

mg/l

0.29

420

Cardiac murmurs and other cardiac sounds

260

1.10

0.16

1.1

297.14

290.95

mg/l

0.14

236

Malignant neoplasm of prostate

438

0.94

0.16

1.0

1.1

280.45

274.78

mg/l

0.30

399

Herpesviral [herpes simplex] infections

818

1.05

0.15

1.0

1.1

300.79

292.64

mg/l

0.29

731

Sequelae of infectious and parasitic diseases

214

0.89

0.15

1.0

1.1

292.68

280.79

mg/l

0.30

194

Corneal scars and opacities

1.10

0.15

1.1

1.0

287.50

284.19

mg/l

—

Other surgical follow-up care

1.10

0.15

1.1

1.0

284.25

283.18

mg/l

—

IgA nephropathy (IgA glomerulonephritis)

0.78

0.15

1.2

1.0

243.33

277.23

mg/l

—

Peripheral retinal degeneration

0.79

0.15

1.0

288.33

285.55

mg/l

—

Carcinoma in situ, bladder

0.78

0.15

1.0

314.50

283.72

mg/l

—

Basal cell carcinoma, including avohilmo

128

918

0.96

0.15

1.1

303.64

286.85

mg/l

1.88

108

827

Disorders of eyelid in diseases classified elsewhere

0.75

0.15

1.2

1.1

263.67

287.72

mg/l

—

Other hammer toe(s) (acquired)

404

1.07

0.15

1.1

308.72

296.69

mg/l

0.49

356

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.21

0.15

1.2

1.0

293.20

286.15

mg/l

—

Maternal care for known or suspected malpresentation of fetus

438

1.06

0.14

1.2

1.1

313.22

313.14

mg/l

0.00

395

Multiple myeloma, including Hilmo

1.18

0.14

1.1

1.0

336.91

298.72

mg/l

0.73

Congenital ovarian cysts

112

1.16

0.14

1.0

1.1

278.46

304.49

mg/l

0.64

104

Disorders of ocular muscles, binocular movement, accommodation and refraction

174

1672

1.03

0.14

1.0

1.1

287.79

291.01

mg/l

0.23

155

1511

Motorcycle rider injured in noncollision transport accidents

0.81

0.13

1.0

1.1

284.25

278.53

mg/l

—

Congenital malformations of the circulatory system

456

1.06

0.13

1.0

1.1

300.35

285.77

mg/l

0.48

416

Non-Hodgkin lymphoma, all

1.18

0.12

1.0

298.40

293.25

mg/l

—

Persons with potential health hazards related to communicable diseases

145

1395

1.03

0.12

1.1

295.74

287.75

mg/l

0.46

133

1272

Inflammatory disease of uterus

395

1.06

0.12

1.0

1.1

314.74

301.73

mg/l

0.52

352

Other disorders of eyelid

122

1199

0.97

0.11

1.1

1.0

286.28

293.81

mg/l

0.62

108

1067

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

230

1.09

0.11

1.0

289.68

289.70

mg/l

0.00

207

Glaucoma suspect

995

0.96

0.11

1.0

1.1

294.71

291.75

mg/l

0.17

887

Supervision of normal pregnancy

416

1.04

0.11

1.1

293.53

316.07

mg/l

1.90

380

Malignant neoplasm of breast, ER-negative, including Hilmo

564

1.05

0.11

1.1

1.0

312.98

297.46

mg/l

1.02

500

Blepharochalasis

799

1.04

0.10

1.0

1.1

288.60

293.86

mg/l

0.28

714

Family history of certain disabilities and chronic diseases leading to disablement

146

0.89

0.10

1.2

1.0

270.77

297.39

mg/l

0.52

135

LeFortI or BSSO operation

125

0.88

0.10

1.0

1.1

263.45

287.59

mg/l

1.92

116

Mandibular retrognathia

207

0.91

0.10

1.0

295.16

292.19

mg/l

0.04

192

Polyp of the female genital tract

516

1.04

0.10

1.0

1.1

294.24

885.38

mg/l

0.51

457

Parapsoriasis

1.09

0.09

1.0

323.00

293.51

mg/l

—

Other lesions of median nerve

1.06

0.09

1.0

294.00

289.23

mg/l

—

Glaucoma-related operations

124

0.89

0.09

1.0

298.64

288.93

mg/l

0.30

107

Basal cell carcinoma

120

853

0.97

0.09

1.1

1.0

300.50

287.50

mg/l

1.24

100

765

Superficial injury of neck

1.11

0.09

1.0

1.1

315.83

288.35

mg/l

—

Alopecia areata

1.07

0.08

1.0

285.50

300.66

mg/l

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

107

1.12

0.08

1.0

309.83

290.65

mg/l

0.38

1.02

0.08

1.0

1.1

247.00

281.89

mg/l

—

Patellar tendinitis

0.82

0.08

1.2

1.1

300.60

279.25

mg/l

—

Dissocial personality disorder

0.80

0.08

1.0

1.1

284.20

262.89

mg/l

—

Adenocarcinoma and papillary adenocarcinoma of stomach

0.79

0.08

1.0

322.20

283.67

mg/l

—

Ectropion of eyelid

0.78

0.08

1.0

283.40

290.89

mg/l

—

Postpartum haemorrhage

727

1.03

0.08

1.1

300.21

305.83

mg/l

0.28

656

Inguinal hernia, unilateral

1.08

0.08

1.0

320.57

287.75

mg/l

—

Femoral hernia, unilateral

1.08

0.08

1.0

320.57

287.75

mg/l

—

Inguinal of femoral hernia, unilateral

1.08

0.08

1.0

320.57

287.75

mg/l

—

Other and unspecified iridocyclitis

127

1.10

0.08

1.0

285.57

284.02

mg/l

0.04

109

Injury of nerves and spinal cord at neck level

1.03

0.08

1.1

1.0

273.00

277.71

mg/l

—

Sequelae of injuries of neck and trunk

1.12

0.07

1.3

1.0

318.91

280.52

mg/l

0.65

Viral conjunctivitis

1.12

0.07

1.1

1.0

297.36

296.55

mg/l

0.01

Lesion of sciatic nerve

0.84

0.07

1.0

245.83

294.95

mg/l

—

Exposure to smoke, fire and flames

0.81

0.07

1.0

253.83

280.92

mg/l

—

Malignant melanoma, including Hilmo

431

1.04

0.07

1.1

1.0

292.02

289.48

mg/l

0.08

384

malignant neoplasm of male genital organs

484

0.97

0.07

1.0

1.1

274.89

272.67

mg/l

0.11

441

Other specified disorders of muscle

1.07

0.07

1.1

258.50

277.11

mg/l

—

Sixth [abducent] nerve palsy

1.05

0.07

1.0

251.00

292.60

mg/l

—

Burn and corrosion of trunk

0.87

0.07

1.1

1.0

254.43

290.56

mg/l

—

Carcinoma in situ of other and unspecified sites

0.84

0.07

1.0

318.14

283.12

mg/l

—

Any dementia, excluding more controls

455

0.97

0.07

1.0

282.98

298.12

mg/l

0.86

400

Other erythematous conditions

1.05

0.07

1.0

282.22

286.38

mg/l

—

Other congenital malformations of face and neck

1.02

0.07

1.1

1.0

288.00

291.87

mg/l

—

Malignant neoplasm of breast, HER-negative

502

1.04

0.06

1.1

1.0

311.57

297.71

mg/l

0.77

449

Maternal care for other known or suspected fetal problems

499

1.03

0.06

1.0

1.1

297.75

313.69

mg/l

1.27

450

All dysplastic lesions of the cervix uteri, vagina or vulva

943

1.02

0.06

1.1

309.39

303.15

mg/l

0.44

843

Bilateral sagittal split ramus osteotomy operation

100

0.90

0.06

1.0

1.1

266.67

286.17

mg/l

—

Transient ischemic attack

145

1195

0.98

0.06

1.0

1.1

285.26

291.99

mg/l

0.59

129

1062

Complications of labour and delivery

221

1246

0.99

0.06

1.1

299.15

546.15

mg/l

0.52

202

1107

False labour

108

659

1.02

0.06

1.0

1.1

295.41

310.69

mg/l

1.27

102

598

Preterm labour and delivery

849

0.98

0.05

1.1

305.41

304.71

mg/l

0.03

745

Scabies

494

1.03

0.05

1.1

288.02

284.48

mg/l

0.14

451

HSIL lesion of the cervix uteri, vagina or vulva

627

0.97

0.05

1.1

1.0

308.16

299.43

mg/l

0.44

563

Glaucoma secondary to other eye disorders

100

1.10

0.05

1.0

316.36

291.73

mg/l

0.98

Postpartum haemorrhage due to retained placenta

394

0.96

0.05

1.1

306.45

299.84

mg/l

0.16

369

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

973

1.02

0.04

1.1

289.07

280.41

mg/l

0.56

884

Intermittent heterotropia

150

1.07

0.04

1.0

1.1

250.94

296.73

mg/l

2.41

134

Hyperplasia of prostate

108

623

0.98

0.04

1.0

277.18

276.97

mg/l

0.01

573

Sequelae of other and unspecified infectious and parasitic diseases

180

0.94

0.04

1.0

1.1

293.76

279.63

mg/l

0.32

164

Viral haemorrhagic fevers, not elsewhere classified/unspecified

230

1.04

0.03

1.2

1.1

272.75

287.25

mg/l

0.40

212

Other and unspecified abdominal hernia

102

1.08

0.03

1.1

1.0

316.45

286.05

mg/l

1.00

Malignant neoplasm of skin

152

1031

1.01

0.03

1.1

1.0

299.36

286.82

mg/l

1.33

131

925

Gonarthrosis,primary

319

1976

0.99

0.02

1.0

1.1

288.21

441.02

mg/l

0.51

274

1779

Malignant neoplasm of brain, including Hilmo

128

0.94

0.02

1.2

1.0

291.25

281.79

mg/l

0.18

115

Other specified/unspecified hearing loss

203

1.03

0.01

1.0

287.81

292.48

mg/l

0.14

183

Congenital malformations of heart and great arteries

404

0.98

0.01

1.1

294.25

286.38

mg/l

0.18

369

Artificial joint operation, meniscal resection

335

2180

1.00

0.01

1.1

281.18

426.97

mg/l

0.55

292

1958

Other and/or unspecified nontoxic goitre

186

0.97

0.00

1.1

1.0

290.44

299.47

mg/l

0.25

167

Unspecified lump in breast

426

0.99

0.00

1.2

1.0

308.55

297.96

mg/l

0.54

375

Later onset COPD

403

0.99

0.00

1.1

1.0

302.19

285.88

mg/l

0.78

352

Deep bite

328

1.02

0.00

1.1

282.28

293.06

mg/l

0.39

300

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

144

973

1.00

0.00

1.0

1.1

303.73

286.39

mg/l

2.11

124

876

Sequelae of other external causes

145

1.03

0.00

1.1

305.73

290.40

mg/l

0.46

131

Recurrent dislocation and subluxation of joint

236

1.02

0.00

1.1

285.04

283.80

mg/l

0.03

210

Neovascular glaucoma

1.04

0.00

1.0

322.10

288.70

mg/l

—

Atopic conjunctivitis

114

0.96

0.00

1.0

1.1

270.09

292.17

mg/l

0.89

103

Malignant neoplasm of eye, brain and central nervous system

116

1.03

0.00

1.2

1.0

318.08

279.52

mg/l

0.77

105

Benign lipomatous neoplasm

905

1.01

0.00

1.0

1.1

290.46

287.70

mg/l

0.15

815

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

273

0.99

0.00

1.1

287.81

283.54

mg/l

0.10

244

Schizophrenia

562

1.00

0.00

1.1

289.96

282.02

mg/l

0.34

515

Abrasion of teeth

115

1152

1.00

0.00

1.1

288.17

293.19

mg/l

0.32

104

1029

Arthropod-borne viral fevers and viral haemorrhagic fevers

279

1.00

0.00

1.2

1.1

268.82

288.12

mg/l

0.69

255

Tinnitus

709

1.00

0.00

1.1

286.68

289.61

mg/l

0.11

639

Maternal care for known or suspected disproportion

127

1.02

0.00

1.1

1.0

280.69

309.60

mg/l

0.60

113

Toxic effect of contact with venomous animals

115

1.04

0.00

1.1

1.0

301.17

284.09

mg/l

0.51

101

Other and unspecified disorders of globe

0.00

0.0

1.2

—

255.60

—

Hodgkin lymphoma, hilmo

0.99

0.00

1.2

1.0

331.78

283.54

mg/l

—

Other diseases of spinal cord

0.98

0.00

1.0

281.00

278.79

mg/l

—

Pedestrian injured in collision with pedal cycle

0.92

0.00

1.0

292.63

287.55

mg/l

—

Female infertility, uterine origin

0.00

0.0

1.0

—

264.60

—

Congenital mitral valve regurgitation

0.00

0.0

1.2

—

268.83

—

Maxillary retrognathism

1.02

-0.00

1.2

1.0

251.60

297.36

mg/l

—

Contact with lifting and transmission devices, not elsewhere classified

0.95

-0.00

1.0

279.50

271.02

mg/l

—

Myeloid leukaemia

0.87

-0.00

1.2

1.0

326.17

279.27

mg/l

—

Major anomalies of jaw size

0.98

-0.00

1.1

1.0

286.63

284.68

mg/l

—

Sacrococcygeal disorders, not elsewhere classified

0.92

-0.00

1.1

295.57

294.40

mg/l

—

Viral conjunctivitis

0.91

-0.00

1.2

1.1

302.00

287.35

mg/l

—

Other specified and unspecified disorders of eye and adnexa

0.92

-0.00

1.1

1.0

321.33

286.43

mg/l

—

Polyglandular dysfunction

0.00

-0.00

0.0

1.0

—

282.20

—

Exposure to sunlight

0.00

-0.00

0.0

1.0

—

286.67

—

Aggressive periodontitis

0.93

-0.00

1.0

239.40

279.91

mg/l

—

Rheumatic heart disease, other

0.00

-0.00

0.0

1.2

—

280.83

—

Other sideroblastic anaemias

0.00

-0.00

0.0

1.2

—

278.50

—

Osteogenesis imperfecta

0.00

-0.00

0.0

1.2

—

294.60

—

Problems related to social environment

0.95

-0.00

1.2

1.1

44561.00

295.02

mg/l

—

Thromboangiitis obliterans

0.00

-0.00

0.0

1.1

—

265.43

—

Disorders of amino-acid transport

0.00

-0.00

0.0

1.0

—

315.20

—

Imperforate hymen

0.00

-0.00

0.0

1.2

—

287.80

—

Other, unspecified and serous retinal detachments

0.89

-0.00

1.1

1.0

273.43

286.88

mg/l

—

Eccrine sweat disorders

0.00

-0.00

0.0

1.0

—

308.60

—

Degenerative conditions of globe

0.00

-0.00

0.0

1.0

—

266.00

—

Polycystic kidney disease

0.96

-0.00

1.1

1.0

380.43

277.74

mg/l

—

Assault by other and unspecified firearm discharge

0.00

-0.00

0.0

1.0

—

251.67

—

Primary angle-closure glaucoma

0.93

-0.00

1.1

1.0

289.67

298.78

mg/l

—

Pneumonia due to other infectious organisms, not elsewhere classified

0.92

-0.00

1.1

1.0

328.63

284.96

mg/l

—

Benign neoplasm: Renal pelvis

0.00

-0.00

0.0

1.2

—

239.60

—

Exposure to high and low air pressure and changes in air pressure

0.00

-0.00

0.0

1.2

—

239.60

—

Other specified/unspecified spondylopathies

0.93

-0.00

1.0

280.40

282.09

mg/l

—

Disorder of visual pathways, unspecified

0.00

-0.00

0.0

1.2

—

286.20

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.0

—

241.40

—

Malignant neoplasm of nasopharynx

0.00

-0.00

0.0

1.0

—

285.20

—

Malignant neoplasm of thymus

0.00

-0.00

0.0

1.1

—

293.71

—

Injury of blood vessels of thorax

0.00

-0.00

0.0

1.1

—

278.57

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

0.00

-0.00

0.0

1.0

—

280.00

—

Periodontal disease, other/unspecified

0.91

-0.00

1.0

1.1

312.86

292.66

mg/l

—

Other and unspecified erythematous conditions

0.93

-0.00

1.0

1.1

302.14

289.87

mg/l

—

Ebstein's anomaly

0.00

-0.00

0.0

1.2

—

298.80

—

Bruxism

0.94

-0.00

1.0

1.1

294.60

295.11

mg/l

—

Follicular keratosis (Darier-White)

0.00

-0.00

0.0

1.2

—

297.67

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.0

—

285.60

—

Hyperaldosteronism

0.91

-0.00

1.0

249.33

282.11

mg/l

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

267.60

—

Malignant neoplasm of brain

0.98

-0.00

1.2

1.0

300.11

281.09

mg/l

—

Noonan syndrome

0.00

-0.00

0.0

1.2

—

280.00

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ceruloplasmin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS